WO2019059392A1 - Foamy skin cleanser - Google Patents

Foamy skin cleanser Download PDF

Info

Publication number
WO2019059392A1
WO2019059392A1 PCT/JP2018/035298 JP2018035298W WO2019059392A1 WO 2019059392 A1 WO2019059392 A1 WO 2019059392A1 JP 2018035298 W JP2018035298 W JP 2018035298W WO 2019059392 A1 WO2019059392 A1 WO 2019059392A1
Authority
WO
WIPO (PCT)
Prior art keywords
component
fatty acid
foam
skin cleanser
polyethylene glycol
Prior art date
Application number
PCT/JP2018/035298
Other languages
French (fr)
Japanese (ja)
Inventor
拓也 山科
俊樹 藤本
康輝 稲田
Original Assignee
株式会社マンダム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2017183578A external-priority patent/JP7121476B2/en
Application filed by 株式会社マンダム filed Critical 株式会社マンダム
Priority to CN201880030689.9A priority Critical patent/CN110612094A/en
Priority to KR1020197033224A priority patent/KR20190133782A/en
Publication of WO2019059392A1 publication Critical patent/WO2019059392A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/74Carboxylates or sulfonates esters of polyoxyalkylene glycols
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/04Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/08Liquid soap, e.g. for dispensers; capsuled
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48Thickener, Thickening system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds

Definitions

  • the present invention relates to foam skin cleansers.
  • foam skin cleansing agents such as face wash and hand soap
  • foam skin cleansing agents that form bubbles by discharging from pump-type or aerosol-type former containers are known as ones that can be easily foamed during use.
  • Patent Documents 1 to 3 properties such as ease of foaming (foaming power), foam quality, and foam persistence (foam retention) are emphasized.
  • the foam for example, a dense and creamy foam having a fine foam formed at a high density is required.
  • a detergent containing a higher fatty acid salt as a main surfactant component as in Patent Document 1 has high foaming power and is excellent in foam quality.
  • the skin may feel firm after washing.
  • the higher fatty acid salt may be precipitated to cause discharge failure, so it is necessary to take measures to suppress the precipitation.
  • detergents that do not contain higher fatty acid salts such as Patent Documents 2 and 3, may be inferior in terms of foaming power and fineness of foam.
  • An object of the present invention is to provide a foamy skin cleanser which contains a higher fatty acid and / or a salt thereof and suppresses the feeling of skin firmness after washing and the precipitation of higher fatty acid.
  • the present invention is a foam-like skin cleansing agent in which an undiluted solution and a propellant are filled in an aerosol container, and the undiluted solution contains the following component A, component B, component C, and component D. It relates to a foam skin cleanser.
  • Component A Higher fatty acid and / or salt thereof
  • Component B Fatty acid ester oil component liquid at room temperature
  • Component C Water component D: Polyethylene glycol fatty acid ester type nonionic surfactant
  • a foamy skin cleanser which suppresses the feeling of skin firmness after washing and the precipitation of higher fatty acids while containing higher fatty acids and / or salts thereof.
  • the foam skin cleanser of the present invention is one in which an undiluted solution and a propellant are filled in an aerosol container.
  • the foamy skin cleanser of the present invention forms a foam during use, i.e. when discharged from the aerosol container and / or after adhering to a subject.
  • each component of the foam-like skin cleanser of the present invention will be described.
  • the above stock solution contains component A: higher fatty acid and / or a salt thereof, component B: fatty acid ester oil liquid at room temperature, component C: water, and component D: polyethylene glycol fatty acid ester type nonionic surfactant as essential components contains.
  • stock solution further contains component E: polyhydric alcohol, component F: thickening compound etc. in addition to the said essential component. Further, components (other components) other than the components A to F may be further contained. The components A to F and other components may be used alone or in combination of two or more.
  • Component A is a higher fatty acid and / or a salt thereof, that is, one or both of a higher fatty acid and a higher fatty acid salt.
  • the component A acts as a cleansing component to enhance the detergency of the foamy skin cleansing agent, and is effective for improving the foamability and latheriness of the foamy skin cleansing agent. Furthermore, it is effective to form a dense foam having a high foam density.
  • the said component A may use only 1 type, and may use 2 or more types.
  • higher fatty acids examples include higher fatty acids having 12 to 22 carbon atoms such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid and behenic acid; vegetable oils and fats such as olive oil, coconut oil, palm oil and cottonseed oil And animal fats and oils such as fish oil and beef tallow.
  • higher fatty acids having 12 to 22 carbon atoms are preferable, and lauric acid, myristic acid, palmitic acid and stearic acid are more preferable, from the viewpoints of detergency, foamability and foaminess of foam skin cleansing agents.
  • salts of the above-mentioned higher fatty acid salts include alkali metal salts such as sodium salt and potassium salt; and alkanolamine salts such as monoethanolamine salt, diethanolamine salt and triethanolamine salt.
  • the higher fatty acid salt may be blended with the higher fatty acid salt previously prepared to be a salt, or the higher fatty acid and the base may form a salt in a stock solution.
  • the content of Component A in 100% by mass of the stock solution is preferably 0.1 to 10.0% by mass, more preferably 0.5 to 8.0% by mass, and still more preferably 1.0 to It is 5.0 mass%.
  • the content is 0.1% by mass or more, the foam resistance is further improved, which is preferable.
  • the clogging of the aerosol by precipitation of the component A is further suppressed because the said content is 10.0 mass% or less, it is preferable.
  • the said content is a total amount of content (The content when converted as a higher fatty acid) of all the components A contained in a undiluted
  • Component B is a fatty acid ester oil which is liquid at room temperature.
  • fatty acid ester oil which is liquid at room temperature is one having a viscosity (B-type viscometer: VISCOMETER TV-25 (manufactured by Toki Sangyo Co., Ltd.)) of 100 mPa ⁇ s or less at 25 ° C. Point to It has been newly found that Component B has the effect of suppressing precipitation of Component A, in addition to suppressing the feeling of skin firmness after washing.
  • the said component B may use only 1 type, and may use 2 or more types.
  • ester oil of linear fatty acid and branched lower alcohol for example, ester oil of linear fatty acid and linear higher alcohol, ester oil of linear fatty acid and branched higher alcohol, branched fatty acid and linear
  • ester oils with higher alcohols for example, ester oils with branched fatty acids and branched higher alcohols, ester oils with fatty acids and polyhydric alcohols, and ester oils with dibasic acids.
  • ester oil of the linear fatty acid and the branched lower alcohol examples include isopropyl myristate, isopropyl palmitate, and isopropyl linoleate.
  • ester oil of linear fatty acid and linear higher alcohol examples include cetyl caprylate, hexyl laurate, decyl myristate, decyl oleate, and oleyl oleate.
  • ester oils of linear fatty acids and branched higher alcohols include isostearyl laurate, isotridecyl myristate, 2-hexyldecyl myristate, isostearyl myristate, octyldodecyl myristate, 2-ethylhexyl palmitate, palmitin Isocetyl acid, isostearyl palmitate, 2-ethylhexyl stearate, isocetyl stearate, isodecyl oleate, octyldodecyl oleate, octyldodecyl linoleate and the like.
  • ester oil of the branched fatty acid and the linear higher alcohol examples include cetyl 2-ethylhexanoate, cetostearyl 2-ethylhexanoate, stearyl 2-ethylhexanoate, and hexyl isostearate.
  • ester oils of the above branched fatty acids and branched higher alcohols include 2-hexyldecyl 2-ethylhexanoate, isostearyl 2-ethylhexanoate, octyldodecyl dimethyl octanoate, 2-ethylhexyl isopalmitate, and isocetyl isostearate.
  • isostearic acid isostearyl, octyldodecyl isostearate, and isononyl isononanoate, and the like.
  • ester oils of fatty acids and polyhydric alcohols include ethylene glycol dioleate, propylene glycol dicaprylate, propylene glycol di (caprylic capric acid), propylene glycol dicaprate, propylene glycol dicaprate, and neopentyl glycol dicaprate.
  • ester oil of the dibasic acid examples include diisopropyl adipate, diisobutyl adipate, dioctyl adipate, diisopropyl sebacate, dioctyl sebacate and the like.
  • the content of component B in 100% by mass of the stock solution is preferably 0.1 to 5.0% by mass, more preferably 0.3 to 4.0% by mass, and still more preferably 0.5 to It is 3.0 mass%.
  • the said content is 0.1 mass% or more, in order to suppress the pinch feeling of the skin after washing
  • the said content is 5.0 mass% or less, in order to maintain foaminess, it is preferable.
  • the above content is the total amount of the content of all the components B contained in the stock solution.
  • the stock solution may optionally further contain a fatty acid ester oil which is solid at room temperature.
  • fatty acid ester oil which is solid at room temperature means that 50 g of fatty acid ester oil is placed in a 70 mL mayonnaise bottle at 25 ° C., and this container is inclined at 45 ° for 30 seconds. It does not run down, it is a thing from the paste to the solid state.
  • the fatty acid ester oil which is solid at room temperature has the effect of suppressing the firmness of the skin after washing and forming a fine, firm and dense foam of texture.
  • One type of fatty acid ester oil which is solid at room temperature may be used, or two or more types may be used.
  • the content of the fatty acid ester oil solid at room temperature in 100% by mass of the stock solution is preferably 0.01 to 4.0% by mass, more preferably 0.05 to 3.5% by mass, and further Preferably, it is 0.1 to 3.0% by mass.
  • the content is 0.01% by mass or more, it is preferable in order to suppress the feeling of firmness of the skin after washing and to form a fine, firm and dense foam of texture.
  • cleaning can be suppressed by the said content being 4.0 mass% or less, it is preferable.
  • the above content is the total content of all room temperature solid fatty acid ester oils contained in the stock solution.
  • the water of Component C is not particularly limited as long as it can be used as a cosmetic raw material, but in general, purified water is preferably used.
  • the content of the component C in 100% by mass of the stock solution is preferably 60.0% by mass or more, more preferably 70.0% by mass or more, from the viewpoint of preventing solidification of the discharged matter, and liquefaction of the discharged matter From the viewpoint of preventing, 98.0 mass% or less is preferable, and 90.0 mass% or less is more preferable.
  • Component D is a polyethylene glycol fatty acid ester type nonionic surfactant.
  • the component D can more effectively suppress the precipitation of the component A.
  • it forms a dense foam with a high foam density, and exhibits the effect of improving the foam resistance of the foam.
  • the said component D may use only 1 type, and may use 2 or more types.
  • component D the component chosen from polyethyleneglycol fatty acid monoester and polyethyleneglycol fatty acid diester is mentioned, for example.
  • polyethylene glycol fatty acid monoester examples include polyethylene glycol monolaurate, polyethylene glycol monostearate, polyethylene glycol monoisostearate, and polyethylene glycol monooleate.
  • polyethylene glycol fatty acid diester examples include polyethylene glycol dilaurate, polyethylene glycol distearate, polyethylene glycol diisostearate, and polyethylene glycol dioleate.
  • the fatty acid in the component D is preferably a fatty acid having 8 to 24 carbon atoms, more preferably a fatty acid having 10 to 20 carbon atoms, and still more preferably a carbon number, from the viewpoint of more effectively suppressing precipitation of the component A.
  • the average addition mole number of ethylene oxide in the component D is preferably 10 to 300, more preferably 12 to 250, from the viewpoint of more effectively suppressing the precipitation of the component A.
  • component D it is preferable to use a component selected from polyethylene glycol monostearate, polyethylene glycol monoisostearate, polyethylene glycol distearate, and polyethylene glycol diisostearate.
  • the content of component D in 100% by mass of the stock solution is preferably 0.01 to 5.0% by mass, more preferably 0.05 to 4%, from the viewpoint of more effectively suppressing precipitation of component A.
  • the content is 0.1% by mass, more preferably 0.1 to 2.0% by mass.
  • the above content is the total amount of the content of all the components D contained in the stock solution.
  • the stock solution may optionally further contain a nonionic surfactant such as a sorbitan fatty acid ester type nonionic surfactant.
  • a nonionic surfactant such as a sorbitan fatty acid ester type nonionic surfactant.
  • sorbitan fatty acid ester type nonionic surfactants are effective for the formation of firm and dense bubbles.
  • Nonionic surfactants other than component D may use only 1 type, and may use 2 or more types.
  • sorbitan fatty acid ester type nonionic surfactant examples include a component selected from sorbitan fatty acid ester and ethylene oxide condensate of sorbitan fatty acid ester.
  • sorbitan fatty acid esters examples include sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan monoisostearate, sorbitan monooleate, sorbitan coconut oil fatty acid, sorbitan sesquistearate, sorbitan sesquiisostearate, sesquiolein Sorbitan acid, sorbitan distearate, sorbitan tristearate, sorbitan trioleate and the like can be mentioned.
  • Examples of the ethylene oxide condensates of sorbitan fatty acid esters include polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monoisostearate, polyoxyethylene sorbitan monoisostearate, and polyoxyoleate monooleate.
  • Examples thereof include ethylene sorbitan, coconut oil fatty acid polyoxyethylene sorbitan, polyoxyethylene sorbitan tristearate, and polyoxyethylene sorbitan trioleate.
  • the fatty acid in the sorbitan fatty acid ester type nonionic surfactant is preferably a fatty acid having 8 to 24 carbon atoms, more preferably 10 carbon atoms, from the viewpoint of exerting firm and dense foam formation more effectively. It is a fatty acid of ⁇ 20, more preferably a fatty acid having 12 to 18 carbon atoms.
  • the average addition mole number of ethylene oxide when the sorbitan fatty acid ester type nonionic surfactant is an ethylene oxide condensate is preferably 5 to 10 from the viewpoint of exerting firm and dense foam formation more effectively. 200, more preferably 6 to 150.
  • sorbitan monopalmitate coconut oil fatty acid sorbitan
  • poly monopalmitate from the viewpoint of exerting firm and dense foam formation more effectively. It is preferable to use a component selected from oxyethylene sorbitan, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monoisostearate, polyoxyethylene sorbitan tristearate, and polyoxyethylene sorbitan trioleate, and coconut oil fatty acid sorbitan It is more preferable to use a component selected from polyoxyethylene sorbitan monostearate and monostearate.
  • the content of the sorbitan fatty acid ester type nonionic surfactant in 100% by mass of the stock solution is From the viewpoint of forming a dense foam, preferably 0.05 to 5.0% by mass, more preferably 0.1 to 4.0% by mass, and still more preferably 0.1 to 3.0%. It is mass%.
  • the above content is the total content of the contents of all sorbitan fatty acid ester type nonionic surfactants contained in the stock solution.
  • the stock solution preferably further contains a polyhydric alcohol of component E.
  • Component E can more effectively suppress precipitation of component A.
  • the said component E may use only 1 type, and may use 2 or more types.
  • sugar alcohols such as sorbitol, maltitol, glucosyltrehalose, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, isoprene glycol, dipropylene glycol, polyethylene glycol, 1,3-butylene glycol (1 (1, 3-butanediol), 1,2-butanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, glycerin (1,2,3-butanediol) Propanetriol), diglycerin, polyglycerin, polyoxyethylene methyl glucoside, polyoxypropylene methyl glucoside, etc., and from the viewpoint of being able to alleviate the feeling of skin firmness after washing, and from the viewpoint of making the lather good Et al, it is preferred to include a sugar alcohol.
  • the content of component E in 100% by mass of the stock solution is preferably 0.5 to 20.0% by mass, more preferably 1.0 to 15%, from the viewpoint of more effectively suppressing precipitation of component A.
  • the content is 0.1% by mass, and more preferably 1.0 to 10.0% by mass.
  • the content is the total of the content of all the components E contained in the stock solution.
  • the stock solution further contains a thickening compound selected from component F1: xanthan gum and guar gum; and a component F such as a thickening compound selected from component F2: hydroxypropyl methylcellulose, hydroxyethyl cellulose, and hydroxypropyl cellulose: thickening compound Is preferred.
  • a thickening compound selected from component F1: xanthan gum and guar gum such as a thickening compound selected from component F2: hydroxypropyl methylcellulose, hydroxyethyl cellulose, and hydroxypropyl cellulose: thickening compound Is preferred.
  • the thickening compound of component F has the effect of improving the foam resistance.
  • the said component F may use only 1 type and may use 2 or more types, it is preferable to use the component F1 and the component F2 together.
  • the content of the component F1 in 100% by mass of the stock solution is preferably 0.01 to 0.5% by mass, more preferably 0.03 to 0.4% by mass from the viewpoint of improving the foam resistance. And more preferably 0.05 to 0.3% by mass.
  • the said content is a total amount of content of all the components F1 contained in a undiluted
  • the content of the component F2 in 100% by mass of the stock solution is preferably 0.01 to 0.5% by mass, more preferably 0.02 to 0.4% by mass from the viewpoint of improving the foam resistance. It is more preferably 0.03 to 0.2% by mass.
  • the said content is a total amount of content of all the components F2 contained in a undiluted
  • the stock solution is not particularly limited, but may contain components other than the components A to F (other components).
  • perfumes silicone oils such as cyclopentasiloxane, hydrogen dimethicone, caprylyl methicone, methylphenylpolysiloxane, dimethicone, etc. preservatives such as phenoxyethanol, octoxyglycerin, methyl paraben, etc. menthol, menthyl glyceryl ether, camphor, peppermint oil etc.
  • Cooling agent Anti-inflammatory agent such as dipotassium glycyrrhizinate and stearyl glycyrrhizinate; Extract of plant extract such as peony, peony, loquat, aloe, etc .; Bactericide; Antioxidant such as tocopherol, dibutyl hydroxytoluene; Benzylidene dioxo imidazolidine octyl propionate, diethyl aminohydroxy benzoyl benzoate, t-butyl methoxy dibenzoyl methane, octyl Riazon, ultraviolet absorbents such as 2-ethylhexyl p-methoxycinnamate; chelating agents such as edetate salts; arbutin, whitening agents such as ascorbic acid; silica, talc, may contain such powders such as nylon powder.
  • Anti-inflammatory agent such as dipotassium glycyrrhizinate
  • microbicide examples include isopropylmethylphenol, benzalkonium chloride, hinokitiol, triclosan, dipotassium glycyrrhizinate, and salicylic acid. Among them, isopropylmethylphenol and salicylic acid are more preferable, and salicylic acid is more preferable.
  • the said germicide may use only 1 type and may use 2 or more types.
  • the content of the bactericidal agent in 100% by mass of the stock solution is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, and preferably 2.0% by mass or less, more preferably Is 1.0% by mass or less, more preferably 0.5% by mass or less.
  • a bactericidal effect is effectively acquired as content of a germicide is more than the above-mentioned minimum.
  • content of a germicide is below the said upper limit from a viewpoint of safety
  • the above content is the total of the content of all the germicides contained in the stock solution.
  • the ability to form a thick foam in the foam skin cleanser may be reduced, and HLB 9.0 to 13.0 is used for this problem.
  • the foam quality can be improved by additionally containing a polyethylene glycol type nonionic surfactant.
  • the polyethylene glycol type nonionic surfactant has a PEG chain and has an effect of enlarging the hydration layer by coating the surface of the emulsion, so the emulsion particles are more stable. It can be considered that as a result, even in a system to which a bactericidal agent is added, it is possible to form a foam having a better texture without losing the foam quality.
  • a polyethylene glycol type nonionic surfactant of HLB 9.0 to 13.0 preferably HLB 9.5 to 12.0 from the viewpoint of forming a dense foam.
  • Polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 may contain component D of HLB 9.0 to 13.0, polyethylene of HLB 9.0 to 13.0 other than component D It may further contain a glycol type nonionic surfactant.
  • examples of polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 other than the component D include, for example, polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil and the like.
  • the polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 may be used alone or in combination of two or more.
  • the content of the polyethylene glycol type nonionic surfactant of HLB 9.0 to 13.0 in 100% by mass of the stock solution forms a firm and dense foam. It is preferably 0.3 to 1.5% by mass, more preferably 0.5 to 1.0% by mass, and still more preferably 0.5 to 0.8% by mass.
  • the above content is the total of the content of polyethylene glycol type nonionic surfactant of all HLBs 9.0 to 13.0 contained in the stock solution.
  • propellant examples include known propellants, for example, gases such as air, nitrogen and nitrous oxide (especially compressed gas); liquefied petroleum gas (LPG: liquefied petroleum gas), dimethyl ether (DME: dimethyl ether) And liquefied gases such as isopentane and fluorocarbon.
  • gases such as air, nitrogen and nitrous oxide (especially compressed gas); liquefied petroleum gas (LPG: liquefied petroleum gas), dimethyl ether (DME: dimethyl ether)
  • liquefied gases such as isopentane and fluorocarbon.
  • the propellant may be used alone or in combination of two or more.
  • the content of the propellant in the total amount of 100% by mass of the undiluted solution and the propellant is preferably 2.0 to 20.0% by mass from the viewpoint of preventing the liquefaction of the discharge. Preferably, it is 3.0 to 15.0% by mass.
  • the "propellant content" means the total amount of individual components constituting the propellant.
  • the foamy skin cleanser of the present invention can be produced by known methods. For example, it is possible to exemplify a manufacturing method in which an undiluted solution is filled in an aerosol container, the container is clinched by an aerosol valve, and then a specified amount of propellant is filled from the stem into the container and the injection button is attached.
  • the foam skin cleanser of the present invention is a skin cleanser used to clean skin such as face.
  • the foam skin cleanser of the present invention includes a cleanser, hand soap, body soap, scalp cleanser and the like.
  • the foam skin cleanser according to the present invention suppresses the feeling of skin firmness after washing and the precipitation of higher fatty acids, and therefore is particularly suitable for use as a cleanser for delicate areas such as face cleansers.
  • Examples 1 to 76 and Comparative Examples 1 to 3 95 parts by mass of the stock solution having the composition described in Tables 1 to 12 is filled in an aerosol container ( ⁇ 35 mm ⁇ 105 mm, aluminum can, container full filling amount: 91 ml) and after clinching the aerosol valve into the container, it is liquefied as a propellant 5 parts by mass of petroleum gas (LPG) was filled from the stem and equipped with a suitable spout to obtain a foamy skin cleanser.
  • LPG petroleum gas
  • the total amount of the undiluted solution and the propellant charged in the aerosol container is 50 g.
  • Myristic acid EDENOR C14-99 (manufactured by Emery Oleochemicals) Palmitic acid: EDENOR C14-99 (manufactured by Emery Oleochemicals)
  • Isononyl isononanoate Saracos 99 (manufactured by Nisshin Oillio Group, Inc.) 2-ethylhexyl palmitate: KOYO POC (manufactured by Kyosho Fine Chemical Co., Ltd.) Cetyl 2-ethylhexanoate: Saracos 816 T (manufactured by Nisshin Oillio Group, Inc.)
  • Octyl dodecyl myristate Excepearl OD-M (manufactured by Kao Corporation)
  • Polyethylene glycol monostearate Emanol 3199 VB (manufactured
  • the foam-like skin cleanser foam of each example and each comparative example was discharged onto a Kim towel (quadruple type: Nippon Paper Cress Co., Ltd.) for 1 second in a dome shape. Then, from the distance of 20 cm away from the top end of the dome-shaped foam, 2 push the purified water filled in the pump container (spray discharge amount: 0.5 mL / 1 push), spray the whole foam, and after 30 seconds Lightly press the surface of the foam with a fingertip, and according to the evaluation points 1 to 4 below, Examples 1 to 20, Comparative Examples 1 and 2 for "foam elasticity", and Examples 21 to 76, Comparative Example 3
  • the sensory evaluation was carried out for “foam elasticity” and “foam quality (density of foam)”. In addition, evaluation was performed by 10 evaluation panels, and the result of the evaluation point (score) obtained most by the number of people was made into the result of each sample. The results are shown in Tables 1-12.
  • the foamy skin cleansers of Examples 1 to 76 containing Component A, Component B, Component C, and Component D have suppression of precipitation of higher fatty acids, detergency, foam elasticity, foam retention, cleansing It was excellent about any of the skin condition (the lack of a feeling of tension) after.
  • Comparative Examples 1 and 3 which do not contain Component B and in the foam skin cleansing agent of Comparative Example 2 which does not contain Component D, precipitation of higher fatty acids was observed.
  • foamy skin containing fatty acid ester oil and sorbitan fatty acid ester type nonionic surfactant which are solid at room temperature It can be seen that the cleaning agent can form a dense foam.
  • foams of Examples 74 and 75 containing polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 have the same properties as those of Examples 74 and 75. It turns out that it is preferable.
  • Prescription example 1 (Stock solution) Myristic acid 2.00 Palmitic acid 1.00 Stearic acid 1.00 Triethanolamine 2.90 1,3-butylene glycol 2.00 Polyethylene glycol 2.00 Xanthan gum 0.15 Hydroxypropyl methylcellulose 0.05 Diisopropyl adipate * 1 1.00 Hexa (hydroxystearic acid / stearic acid / rosin acid) dipentaerythrityl 1.00 Coconut oil fatty acid sorbitan 1.00 Polyoxyethylene (20) sorbitan monostearate 1.50 Polyethylene glycol monostearate 1.00 Sorbitol 2.00 Refined water Total 100.00 (Propellant) Liquefied petroleum gas (LPG) 100.00 100.00 in total Undiluted solution 95.00 Propellant 5.00 100.00 in total * 1) Diisopropyl adipate: Matte Lube DIA (manufactured by Seiwa Kasei)
  • Prescription example 2 (Stock solution) Myristic acid 3.00 Triethanolamine 2.35 Dipropylene glycol 4.00 Concentrated glycerin 1.00 Xanthan gum 0.15 Hydroxypropyl cellulose 0.10 Diisobutyl adipate * 2 1.00 Tetra (hydroxystearic acid / isostearic acid) dipentaerythrityl 1.00 Coconut oil fatty acid sorbitan 1.00 Polyoxyethylene (20) sorbitan monostearate 0.75 Polyethylene glycol distearate 0.50 Sorbitol 2.00 Refined water Total 100.00 (Propellant) Liquefied petroleum gas (LPG) 100.00 100.00 in total Undiluted solution 96.00 Propellant 4.00 100.00 in total * 2) Diisobutyl adipate: Matte Lube DIBA (made by Seiwa Kasei)
  • the foamy skin cleanser of the present invention can be used as a cleanser for face, hands, body, scalp and hair.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Provided is a foamy skin cleanser in which a stock solution and a propellant are filled in an aerosol container, wherein the stock solution is characterized by containing components A, B, C and D below, Component A: a higher fatty acid and/or a salt thereof Component B: a fatty acid ester oil which is liquid at room temperature Component C: water Component D: a polyethylene glycol fatty acid ester-type nonionic surfactant. The foamy skin cleanser according to the present invention may be used for the face, hands, body, scalp or hair, etc.

Description

フォーム状皮膚洗浄料Foam skin cleansing agent
 本発明は、フォーム状皮膚洗浄料に関する。 The present invention relates to foam skin cleansers.
 従来、洗顔料やハンドソープ等の皮膚洗浄料の中でも、使用時に簡便に泡立てることができるものとして、ポンプタイプやエアゾールタイプのフォーマー容器より吐出して泡を形成するフォーム状皮膚洗浄料が知られている(例えば、特許文献1~3)。これらのフォーム状皮膚洗浄料では、泡立ち易さ(起泡力)、泡質や、泡の持続性(泡もち)などの特性が重視されている。上記泡質としては、例えば、細かな泡が高密度に形成された、濃密でクリーミーな泡質が求められている。  Among the skin cleansing agents such as face wash and hand soap, foam skin cleansing agents that form bubbles by discharging from pump-type or aerosol-type former containers are known as ones that can be easily foamed during use. (For example, Patent Documents 1 to 3). In these foam skin cleansing agents, properties such as ease of foaming (foaming power), foam quality, and foam persistence (foam retention) are emphasized. As the foam, for example, a dense and creamy foam having a fine foam formed at a high density is required.
特開2012-102194号公報JP 2012-102194 A 特開2007-131585号公報JP 2007-131585 A 特開2012-240985号公報JP 2012-240985
 特許文献1のような、高級脂肪酸塩を主たる界面活性剤成分として含む洗浄料は、起泡力が高く、泡質にも優れる。しかし、例えば、洗顔料などとして使用する場合には、洗顔後に肌のつっぱり感が生じたりする場合がある。また、エアゾールタイプのフォーマー容器で用いる場合には、高級脂肪酸塩が析出して吐出不良が生じる恐れがあるため、析出を抑制する対策を施す必要がある。一方、特許文献2、3のような、高級脂肪酸塩を含まない洗浄料は、起泡力や泡の細かさの点で劣る場合がある。 A detergent containing a higher fatty acid salt as a main surfactant component as in Patent Document 1 has high foaming power and is excellent in foam quality. However, for example, in the case of using as a face wash, the skin may feel firm after washing. In addition, in the case of using it in an aerosol type former container, there is a possibility that the higher fatty acid salt may be precipitated to cause discharge failure, so it is necessary to take measures to suppress the precipitation. On the other hand, detergents that do not contain higher fatty acid salts, such as Patent Documents 2 and 3, may be inferior in terms of foaming power and fineness of foam.
 本発明の課題は、高級脂肪酸及び/又はその塩を含有しつつも、洗浄後の肌のつっぱり感及び高級脂肪酸の析出を抑制するフォーム状皮膚洗浄料を提供することである。 An object of the present invention is to provide a foamy skin cleanser which contains a higher fatty acid and / or a salt thereof and suppresses the feeling of skin firmness after washing and the precipitation of higher fatty acid.
 本発明は、原液と噴射剤とがエアゾール容器に充填されたフォーム状皮膚洗浄料であって、前記原液が、下記成分A、成分B、成分C、及び成分Dを含有することを特徴とするフォーム状皮膚洗浄料に関する。
成分A:高級脂肪酸及び/又はその塩
成分B:室温で液状の脂肪酸エステル油
成分C:水
成分D:ポリエチレングリコール脂肪酸エステル型非イオン性界面活性剤
The present invention is a foam-like skin cleansing agent in which an undiluted solution and a propellant are filled in an aerosol container, and the undiluted solution contains the following component A, component B, component C, and component D. It relates to a foam skin cleanser.
Component A: Higher fatty acid and / or salt thereof Component B: Fatty acid ester oil component liquid at room temperature Component C: Water component D: Polyethylene glycol fatty acid ester type nonionic surfactant
 本発明によれば、高級脂肪酸及び/又はその塩を含有しつつも、洗浄後の肌のつっぱり感及び高級脂肪酸の析出を抑制するフォーム状皮膚洗浄料を提供することができる。 According to the present invention, it is possible to provide a foamy skin cleanser which suppresses the feeling of skin firmness after washing and the precipitation of higher fatty acids while containing higher fatty acids and / or salts thereof.
 本発明のフォーム状皮膚洗浄料は、原液と噴射剤とがエアゾール容器に充填されているものである。本発明のフォーム状皮膚洗浄料は、使用時、すなわちエアゾール容器から吐出される際に、及び/又は、対象に付着した後に、泡を形成するものである。以下、本発明のフォーム状皮膚洗浄料の各構成成分について説明する。 The foam skin cleanser of the present invention is one in which an undiluted solution and a propellant are filled in an aerosol container. The foamy skin cleanser of the present invention forms a foam during use, i.e. when discharged from the aerosol container and / or after adhering to a subject. Hereinafter, each component of the foam-like skin cleanser of the present invention will be described.
 上記原液は、成分A:高級脂肪酸及び/又はその塩、成分B:室温で液状の脂肪酸エステル油、成分C:水、及び成分D:ポリエチレングリコール脂肪酸エステル型非イオン性界面活性剤を必須成分として含有する。 The above stock solution contains component A: higher fatty acid and / or a salt thereof, component B: fatty acid ester oil liquid at room temperature, component C: water, and component D: polyethylene glycol fatty acid ester type nonionic surfactant as essential components contains.
 上記原液は、上記必須成分に加えて、成分E:多価アルコール、成分F:増粘性化合物などをさらに含有することが好ましい。また、成分A~F以外の成分(その他の成分)をさらに含有してもよい。成分A~Fやその他の成分は、それぞれ、1種のみを用いてもよいし、2種以上を用いてもよい。 It is preferable that the said undiluted | stock solution further contains component E: polyhydric alcohol, component F: thickening compound etc. in addition to the said essential component. Further, components (other components) other than the components A to F may be further contained. The components A to F and other components may be used alone or in combination of two or more.
 成分Aは、高級脂肪酸及び/又はその塩、即ち、高級脂肪酸及び高級脂肪酸塩のうちのいずれか一方又は両方である。成分Aは、洗浄成分として作用しフォーム状皮膚洗浄料の洗浄力を高めるとともに、フォーム状皮膚洗浄料の起泡性及び泡もちの向上に効果的である。さらに、泡密度の高い濃密な泡を形成することに効果的である。上記成分Aは、1種のみを用いてもよいし、2種以上を用いてもよい。 Component A is a higher fatty acid and / or a salt thereof, that is, one or both of a higher fatty acid and a higher fatty acid salt. The component A acts as a cleansing component to enhance the detergency of the foamy skin cleansing agent, and is effective for improving the foamability and latheriness of the foamy skin cleansing agent. Furthermore, it is effective to form a dense foam having a high foam density. The said component A may use only 1 type, and may use 2 or more types.
 上記高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、ベヘニン酸等の炭素数12~22の高級脂肪酸;オリーブ油、ヤシ油、パーム油、綿実油等の植物性油脂;魚油、牛脂等の動物性油脂等が挙げられる。中でも、フォーム状皮膚洗浄料の洗浄力、起泡性、泡もちの観点から、炭素数12~22の高級脂肪酸が好ましく、ラウリン酸、ミリスチン酸、パルミチン酸、及びステアリン酸がより好ましい。 Examples of the higher fatty acids include higher fatty acids having 12 to 22 carbon atoms such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid and behenic acid; vegetable oils and fats such as olive oil, coconut oil, palm oil and cottonseed oil And animal fats and oils such as fish oil and beef tallow. Among them, higher fatty acids having 12 to 22 carbon atoms are preferable, and lauric acid, myristic acid, palmitic acid and stearic acid are more preferable, from the viewpoints of detergency, foamability and foaminess of foam skin cleansing agents.
 上記高級脂肪酸塩における塩としては、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩;モノエタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩等のアルカノールアミン塩等が挙げられる。 Examples of salts of the above-mentioned higher fatty acid salts include alkali metal salts such as sodium salt and potassium salt; and alkanolamine salts such as monoethanolamine salt, diethanolamine salt and triethanolamine salt.
 上記高級脂肪酸塩は、予め塩に調製された高級脂肪酸塩が配合されていてもよいし、高級脂肪酸と塩基とが原液中で塩を形成していてもよい。 The higher fatty acid salt may be blended with the higher fatty acid salt previously prepared to be a salt, or the higher fatty acid and the base may form a salt in a stock solution.
 原液100質量%中の、成分Aの含有量は、好ましくは0.1~10.0質量%であり、より好ましくは0.5~8.0質量%であり、さらに好ましくは1.0~5.0質量%である。上記含有量が0.1質量%以上であることにより、泡もちがより一層向上するため好ましい。また、上記含有量が10.0質量%以下であることにより、成分Aの析出によるエアゾールの詰まりがより一層抑制されるため好ましい。上記含有量は、原液中に含まれる全ての成分Aの含有量(高級脂肪酸として換算した場合の含有量)の合計量である。 The content of Component A in 100% by mass of the stock solution is preferably 0.1 to 10.0% by mass, more preferably 0.5 to 8.0% by mass, and still more preferably 1.0 to It is 5.0 mass%. When the content is 0.1% by mass or more, the foam resistance is further improved, which is preferable. Moreover, since the clogging of the aerosol by precipitation of the component A is further suppressed because the said content is 10.0 mass% or less, it is preferable. The said content is a total amount of content (The content when converted as a higher fatty acid) of all the components A contained in a undiluted | stock solution.
 成分Bは室温で液状の脂肪酸エステル油である。本明細書において、室温で液状の脂肪酸エステル油とは、25℃の条件下において、粘度(B型粘度計:VISCOMETER TV-25(東機産業社製))が100mPa・s以下の性状のものを指す。成分Bには、洗浄後の肌のつっぱり感を抑制すると共に、さらに成分Aの析出抑制効果があることを新たに見出した。上記成分Bは、1種のみを用いてもよいし、2種以上を用いてもよい。 Component B is a fatty acid ester oil which is liquid at room temperature. In the present specification, fatty acid ester oil which is liquid at room temperature is one having a viscosity (B-type viscometer: VISCOMETER TV-25 (manufactured by Toki Sangyo Co., Ltd.)) of 100 mPa · s or less at 25 ° C. Point to It has been newly found that Component B has the effect of suppressing precipitation of Component A, in addition to suppressing the feeling of skin firmness after washing. The said component B may use only 1 type, and may use 2 or more types.
 上記成分Bとしては、例えば、直鎖脂肪酸と分岐低級アルコールとのエステル油、直鎖脂肪酸と直鎖高級アルコールとのエステル油、直鎖脂肪酸と分岐高級アルコールとのエステル油、分岐脂肪酸と直鎖高級アルコールとのエステル油、分岐脂肪酸と分岐高級アルコールとのエステル油、脂肪酸と多価アルコールとのエステル油、及び二塩基酸のエステル油から選ばれる成分が挙げられる。 As said component B, for example, ester oil of linear fatty acid and branched lower alcohol, ester oil of linear fatty acid and linear higher alcohol, ester oil of linear fatty acid and branched higher alcohol, branched fatty acid and linear Examples thereof include components selected from ester oils with higher alcohols, ester oils with branched fatty acids and branched higher alcohols, ester oils with fatty acids and polyhydric alcohols, and ester oils with dibasic acids.
 上記直鎖脂肪酸と分岐低級アルコールとのエステル油としては、例えば、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、及びリノール酸イソプロピル等が挙げられる。 Examples of the ester oil of the linear fatty acid and the branched lower alcohol include isopropyl myristate, isopropyl palmitate, and isopropyl linoleate.
 上記直鎖脂肪酸と直鎖高級アルコールとのエステル油としては、例えば、カプリル酸セチル、ラウリン酸ヘキシル、ミリスチン酸デシル、オレイン酸デシル、及びオレイン酸オレイル等が挙げられる。 Examples of the ester oil of linear fatty acid and linear higher alcohol include cetyl caprylate, hexyl laurate, decyl myristate, decyl oleate, and oleyl oleate.
 上記直鎖脂肪酸と分岐高級アルコールとのエステル油としては、例えば、ラウリン酸イソステアリル、ミリスチン酸イソトリデシル、ミリスチン酸2-ヘキシルデシル、ミリスチン酸イソステアリル、ミリスチン酸オクチルドデシル、パルミチン酸2-エチルヘキシル、パルミチン酸イソセチル、パルミチン酸イソステアリル、ステアリン酸2-エチルヘキシル、ステアリン酸イソセチル、オレイン酸イソデシル、オレイン酸オクチルドデシル、及びリノール酸オクチルドデシル等が挙げられる。 Examples of ester oils of linear fatty acids and branched higher alcohols include isostearyl laurate, isotridecyl myristate, 2-hexyldecyl myristate, isostearyl myristate, octyldodecyl myristate, 2-ethylhexyl palmitate, palmitin Isocetyl acid, isostearyl palmitate, 2-ethylhexyl stearate, isocetyl stearate, isodecyl oleate, octyldodecyl oleate, octyldodecyl linoleate and the like.
 上記分岐脂肪酸と直鎖高級アルコールとのエステル油としては、例えば、2-エチルヘキサン酸セチル、2-エチルヘキサン酸セトステアリル、2-エチルヘキサン酸ステアリル、及びイソステアリン酸ヘキシル等が挙げられる。 Examples of the ester oil of the branched fatty acid and the linear higher alcohol include cetyl 2-ethylhexanoate, cetostearyl 2-ethylhexanoate, stearyl 2-ethylhexanoate, and hexyl isostearate.
 上記分岐脂肪酸と分岐高級アルコールとのエステル油としては、例えば、2-エチルヘキサン酸2-ヘキシルデシル、2-エチルヘキサン酸イソステアリル、ジメチルオクタン酸オクチルドデシル、イソパルミチン酸2-エチルヘキシル、イソステアリン酸イソセチル、イソステアリン酸イソステアリル、イソステアリン酸オクチルドデシル、及びイソノナン酸イソノニル等が挙げられる。 Examples of ester oils of the above branched fatty acids and branched higher alcohols include 2-hexyldecyl 2-ethylhexanoate, isostearyl 2-ethylhexanoate, octyldodecyl dimethyl octanoate, 2-ethylhexyl isopalmitate, and isocetyl isostearate. And isostearic acid isostearyl, octyldodecyl isostearate, and isononyl isononanoate, and the like.
 上記脂肪酸と多価アルコールとのエステル油としては、例えば、ジオレイン酸エチレングリコール、ジカプリル酸プロピレングリコール、ジ(カプリル・カプリン酸)プロピレングリコール、ジカプリン酸プロピレングリコール、ジオレイン酸プロピレングリコール、ジカプリン酸ネオペンチルグリコール、ジオクタン酸ネオペンチルグリコール、トリ2-エチルヘキサン酸グリセリル、トリ(カプリル・カプリン酸)グリセリル、トリイソステアリン酸グリセリル、トリ2-エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ2-エチルヘキサン酸ペンタエリスリトール、及びテトライソステアリン酸ペンタエリスリトール等が挙げられる。 Examples of ester oils of fatty acids and polyhydric alcohols include ethylene glycol dioleate, propylene glycol dicaprylate, propylene glycol di (caprylic capric acid), propylene glycol dicaprate, propylene glycol dicaprate, and neopentyl glycol dicaprate. , Neopentyl glycol dioctanoate, glyceryl tri-2-ethylhexanoate, glyceryl tri (caprylic caprate), glyceryl triisostearate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, tetra 2-ethyl ester Examples thereof include pentaerythritol hexanoate and pentaerythritol tetraisostearate.
 上記二塩基酸のエステル油としては、例えば、アジピン酸ジイソプロピル、アジピン酸ジイソブチル、アジピン酸ジオクチル、セバシン酸ジイソプロピル、及びセバシン酸ジオクチル等が挙げられる。 Examples of the ester oil of the dibasic acid include diisopropyl adipate, diisobutyl adipate, dioctyl adipate, diisopropyl sebacate, dioctyl sebacate and the like.
 本発明においては、上記成分Bの中でも、洗浄後の肌のつっぱり感を抑制し、さらに上記成分Aの析出を抑制させる観点から、直鎖脂肪酸と分岐低級アルコールとのエステル油、直鎖脂肪酸と分岐高級アルコールとのエステル油、分岐脂肪酸と直鎖高級アルコールとのエステル油、分岐脂肪酸と分岐高級アルコールとのエステル油、及び二塩基酸のエステル油から選ばれる成分を用いることが好ましく、ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、パルミチン酸2-エチルヘキシル、2-エチルヘキサン酸セチル、イソノナン酸イソノニル、アジピン酸ジイソブチル、及びアジピン酸ジイソプロピルから選ばれる成分を用いることがより好ましい。 In the present invention, among the components B, from the viewpoint of suppressing the feeling of skin firmness after washing and further suppressing the precipitation of the component A, an ester oil of a linear fatty acid and a branched lower alcohol, a linear fatty acid and It is preferable to use a component selected from ester oils with branched higher alcohols, ester oils with branched fatty acids and linear higher alcohols, ester oils with branched fatty acids and branched higher alcohols, and ester oils with dibasic acids, myristic acid It is more preferable to use a component selected from isopropyl, octyldodecyl myristate, 2-ethylhexyl palmitate, cetyl 2-ethylhexanoate, isononyl isononanoate, diisobutyl adipate, and diisopropyl adipate.
 原液100質量%中の、成分Bの含有量は、好ましくは0.1~5.0質量%であり、より好ましくは0.3~4.0質量%であり、さらに好ましくは0.5~3.0質量%である。上記含有量が0.1質量%以上であることにより、洗浄後の肌のつっぱり感を抑制し、さらに成分Aの析出を抑制するため好ましい。また、上記含有量が5.0質量%以下であることにより、泡もちを持続させるため好ましい。上記含有量は、原液中に含まれる全ての成分Bの含有量の合計量である。 The content of component B in 100% by mass of the stock solution is preferably 0.1 to 5.0% by mass, more preferably 0.3 to 4.0% by mass, and still more preferably 0.5 to It is 3.0 mass%. When the said content is 0.1 mass% or more, in order to suppress the pinch feeling of the skin after washing | cleaning and also to suppress precipitation of the component A, it is preferable. Moreover, since the said content is 5.0 mass% or less, in order to maintain foaminess, it is preferable. The above content is the total amount of the content of all the components B contained in the stock solution.
 上記成分Bの他、原液中には、任意に、室温で固形状の脂肪酸エステル油がさらに含まれていてもよい。本明細書において、室温で固形状の脂肪酸エステル油とは、25℃の条件下において、70mL容のマヨネーズ瓶に、50gの脂肪酸エステル油を入れ、この容器を斜め45度に30秒間傾けた際に流れ落ちない、ペーストから固形の性状のものを指す。室温で固形状の脂肪酸エステル油は、洗浄後の肌のつっぱり感を抑制すると共に、さらにキメの細かいしっかりとした濃密な泡を形成する効果がある。室温で固形状の脂肪酸エステル油は、1種のみを用いてもよいし、2種以上を用いてもよい。 In addition to the component B, the stock solution may optionally further contain a fatty acid ester oil which is solid at room temperature. In the present specification, fatty acid ester oil which is solid at room temperature means that 50 g of fatty acid ester oil is placed in a 70 mL mayonnaise bottle at 25 ° C., and this container is inclined at 45 ° for 30 seconds. It does not run down, it is a thing from the paste to the solid state. The fatty acid ester oil which is solid at room temperature has the effect of suppressing the firmness of the skin after washing and forming a fine, firm and dense foam of texture. One type of fatty acid ester oil which is solid at room temperature may be used, or two or more types may be used.
 室温で固形状の脂肪酸エステル油としては、例えば、ヘキサ(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)ジペンタエリスリチル、テトラ(ヒドロキシステアリン酸/イソステアリン酸)ジペンタエリスリチル、ヘキサヒドロキシステアリン酸ジペンタエリスリチルなどが挙げられる。 Examples of fatty acid ester oils that are solid at room temperature include hexa (hydroxystearic acid / stearic acid / rosin acid) dipentaerythrityl, tetra (hydroxystearic acid / isostearic acid) dipentaerythrityl, hexahydroxystearate dipentaerythrityl, and the like.
 原液100質量%中の、室温で固形状の脂肪酸エステル油の含有量は、好ましくは0.01~4.0質量%であり、より好ましくは0.05~3.5質量%であり、さらに好ましくは0.1~3.0質量%である。上記含有量が0.01質量%以上であることにより、洗浄後の肌のつっぱり感を抑制し、さらにキメの細かいしっかりとした濃密な泡を形成するため好ましい。また、上記含有量が4.0質量%以下であることにより、洗浄後のべたつき感を抑えることができるため好ましい。上記含有量は、原液中に含まれる全ての室温で固形状の脂肪酸エステル油の含有量の合計量である。 The content of the fatty acid ester oil solid at room temperature in 100% by mass of the stock solution is preferably 0.01 to 4.0% by mass, more preferably 0.05 to 3.5% by mass, and further Preferably, it is 0.1 to 3.0% by mass. When the content is 0.01% by mass or more, it is preferable in order to suppress the feeling of firmness of the skin after washing and to form a fine, firm and dense foam of texture. Moreover, since the sticky feeling after washing | cleaning can be suppressed by the said content being 4.0 mass% or less, it is preferable. The above content is the total content of all room temperature solid fatty acid ester oils contained in the stock solution.
 成分Cの水は、化粧品原料として使用できるものであれば特に限定されないが、通常、精製水が好ましく用いられる。 The water of Component C is not particularly limited as long as it can be used as a cosmetic raw material, but in general, purified water is preferably used.
 原液100質量%中の、成分Cの含有量は、吐出物の固化を防止する観点から、60.0質量%以上が好ましく、70.0質量%以上がより好ましく、また、吐出物の液化を防止する観点から、98.0質量%以下が好ましく、90.0質量%以下がより好ましい。 The content of the component C in 100% by mass of the stock solution is preferably 60.0% by mass or more, more preferably 70.0% by mass or more, from the viewpoint of preventing solidification of the discharged matter, and liquefaction of the discharged matter From the viewpoint of preventing, 98.0 mass% or less is preferable, and 90.0 mass% or less is more preferable.
 成分Dは、ポリエチレングリコール脂肪酸エステル型非イオン性界面活性剤である。成分Dは、成分Aの析出抑制をより効果的に高めることができる。また、泡密度の高い濃密な泡を形成し、その泡の泡もちを向上させる効果も発揮する。上記成分Dは、1種のみを用いてもよいし、2種以上を用いてもよい。 Component D is a polyethylene glycol fatty acid ester type nonionic surfactant. The component D can more effectively suppress the precipitation of the component A. In addition, it forms a dense foam with a high foam density, and exhibits the effect of improving the foam resistance of the foam. The said component D may use only 1 type, and may use 2 or more types.
 上記成分Dとしては、例えば、ポリエチレングリコール脂肪酸モノエステル、及びポリエチレングリコール脂肪酸ジエステルから選ばれる成分が挙げられる。 As said component D, the component chosen from polyethyleneglycol fatty acid monoester and polyethyleneglycol fatty acid diester is mentioned, for example.
 上記ポリエチレングリコール脂肪酸モノエステルとしては、例えば、モノラウリン酸ポリエチレングリコール、モノステアリン酸ポリエチレングリコール、モノイソステアリン酸ポリエチレングリコール、及びモノオレイン酸ポリエチレングリコール等が挙げられる。 Examples of the polyethylene glycol fatty acid monoester include polyethylene glycol monolaurate, polyethylene glycol monostearate, polyethylene glycol monoisostearate, and polyethylene glycol monooleate.
 上記ポリエチレングリコール脂肪酸ジエステルとしては、例えば、ジラウリン酸ポリエチレングリコール、ジステアリン酸ポリエチレングリコール、ジイソステアリン酸ポリエチレングリコール、及びジオレイン酸ポリエチレングリコール等が挙げられる。 Examples of the polyethylene glycol fatty acid diester include polyethylene glycol dilaurate, polyethylene glycol distearate, polyethylene glycol diisostearate, and polyethylene glycol dioleate.
 上記成分Dにおける脂肪酸は、上記成分Aの析出抑制をより効果的に高める観点から、炭素数が8~24の脂肪酸が好ましく、より好ましくは炭素数が10~20の脂肪酸、さらに好ましくは炭素数が12~18の脂肪酸である。 The fatty acid in the component D is preferably a fatty acid having 8 to 24 carbon atoms, more preferably a fatty acid having 10 to 20 carbon atoms, and still more preferably a carbon number, from the viewpoint of more effectively suppressing precipitation of the component A. Is 12 to 18 fatty acids.
 上記成分Dにおける酸化エチレンの平均付加モル数は、上記成分Aの析出抑制をより効果的に高める観点から、好ましくは10~300、より好ましくは12~250である。 The average addition mole number of ethylene oxide in the component D is preferably 10 to 300, more preferably 12 to 250, from the viewpoint of more effectively suppressing the precipitation of the component A.
 本発明においては、上記成分Dの中でも、モノステアリン酸ポリエチレングリコール、モノイソステアリン酸ポリエチレングリコール、ジステアリン酸ポリエチレングリコール、及びジイソステアリン酸ポリエチレングリコールから選ばれる成分を用いることが好ましい。 In the present invention, among the above component D, it is preferable to use a component selected from polyethylene glycol monostearate, polyethylene glycol monoisostearate, polyethylene glycol distearate, and polyethylene glycol diisostearate.
 原液100質量%中の、成分Dの含有量は、成分Aの析出抑制をより効果的に高める観点から、好ましくは0.01~5.0質量%であり、より好ましくは0.05~4.0質量%であり、さらに好ましくは0.1~2.0質量%である。上記含有量は、原液中に含まれる全ての成分Dの含有量の合計量である。 The content of component D in 100% by mass of the stock solution is preferably 0.01 to 5.0% by mass, more preferably 0.05 to 4%, from the viewpoint of more effectively suppressing precipitation of component A. The content is 0.1% by mass, more preferably 0.1 to 2.0% by mass. The above content is the total amount of the content of all the components D contained in the stock solution.
 上記成分Dの他、原液中には、任意に、ソルビタン脂肪酸エステル型非イオン性界面活性剤などの非イオン性界面活性剤がさらに含まれていてもよい。例えば、ソルビタン脂肪酸エステル型非イオン性界面活性剤は、しっかりとした濃密な泡の形成に効果的である。成分D以外の非イオン性界面活性剤は、1種のみを用いてもよいし、2種以上を用いてもよい。 In addition to the above component D, the stock solution may optionally further contain a nonionic surfactant such as a sorbitan fatty acid ester type nonionic surfactant. For example, sorbitan fatty acid ester type nonionic surfactants are effective for the formation of firm and dense bubbles. Nonionic surfactants other than component D may use only 1 type, and may use 2 or more types.
 上記ソルビタン脂肪酸エステル型非イオン性界面活性剤としては、例えば、ソルビタン脂肪酸エステル、並びにソルビタン脂肪酸エステルの酸化エチレン縮合物から選ばれる成分が挙げられる。 Examples of the sorbitan fatty acid ester type nonionic surfactant include a component selected from sorbitan fatty acid ester and ethylene oxide condensate of sorbitan fatty acid ester.
 上記ソルビタン脂肪酸エステルとしては、例えば、モノラウリン酸ソルビタン、モノパルミチン酸ソルビタン、モノステアリン酸ソルビタン、モノイソステアリン酸ソルビタン、モノオレイン酸ソルビタン、ヤシ油脂肪酸ソルビタン、セスキステアリン酸ソルビタン、セスキイソステアリン酸ソルビタン、セスキオレイン酸ソルビタン、ジステアリン酸ソルビタン、トリステアリン酸ソルビタン、及びトリオレイン酸ソルビタン等が挙げられる。 Examples of sorbitan fatty acid esters include sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan monoisostearate, sorbitan monooleate, sorbitan coconut oil fatty acid, sorbitan sesquistearate, sorbitan sesquiisostearate, sesquiolein Sorbitan acid, sorbitan distearate, sorbitan tristearate, sorbitan trioleate and the like can be mentioned.
 上記ソルビタン脂肪酸エステルの酸化エチレン縮合物としては、例えば、モノラウリン酸ポリオキシエチレンソルビタン、モノパルミチン酸ポリオキシエチレンソルビタン、モノステアリン酸ポリオキシエチレンソルビタン、モノイソステアリン酸ポリオキシエチレンソルビタン、モノオレイン酸ポリオキシエチレンソルビタン、ヤシ油脂肪酸ポリオキシエチレンソルビタン、トリステアリン酸ポリオキシエチレンソルビタン、及びトリオレイン酸ポリオキシエチレンソルビタン等が挙げられる。 Examples of the ethylene oxide condensates of sorbitan fatty acid esters include polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monoisostearate, polyoxyethylene sorbitan monoisostearate, and polyoxyoleate monooleate. Examples thereof include ethylene sorbitan, coconut oil fatty acid polyoxyethylene sorbitan, polyoxyethylene sorbitan tristearate, and polyoxyethylene sorbitan trioleate.
 上記ソルビタン脂肪酸エステル型非イオン性界面活性剤における脂肪酸は、しっかりとした濃密な泡形成をより効果的に発揮させる観点から、炭素数が8~24の脂肪酸が好ましく、より好ましくは炭素数が10~20の脂肪酸、さらに好ましくは炭素数が12~18の脂肪酸である。 The fatty acid in the sorbitan fatty acid ester type nonionic surfactant is preferably a fatty acid having 8 to 24 carbon atoms, more preferably 10 carbon atoms, from the viewpoint of exerting firm and dense foam formation more effectively. It is a fatty acid of ̃20, more preferably a fatty acid having 12 to 18 carbon atoms.
 上記ソルビタン脂肪酸エステル型非イオン性界面活性剤が酸化エチレン縮合物である場合の酸化エチレンの平均付加モル数は、しっかりとした濃密な泡形成をより効果的に発揮させる観点から、好ましくは5~200、より好ましくは6~150である。 The average addition mole number of ethylene oxide when the sorbitan fatty acid ester type nonionic surfactant is an ethylene oxide condensate is preferably 5 to 10 from the viewpoint of exerting firm and dense foam formation more effectively. 200, more preferably 6 to 150.
 本発明においては、上記ソルビタン脂肪酸エステル型非イオン性界面活性剤の中でも、しっかりとした濃密な泡形成をより効果的に発揮させる観点から、モノパルミチン酸ソルビタン、ヤシ油脂肪酸ソルビタン、モノパルミチン酸ポリオキシエチレンソルビタン、モノステアリン酸ポリオキシエチレンソルビタン、モノイソステアリン酸ポリオキシエチレンソルビタン、トリステアリン酸ポリオキシエチレンソルビタン、及びトリオレイン酸ポリオキシエチレンソルビタンから選ばれる成分を用いることが好ましく、ヤシ油脂肪酸ソルビタン、及びモノステアリン酸ポリオキシエチレンソルビタンから選ばれる成分を用いることがより好ましい。 In the present invention, among the above sorbitan fatty acid ester type nonionic surfactants, sorbitan monopalmitate, coconut oil fatty acid sorbitan, poly monopalmitate from the viewpoint of exerting firm and dense foam formation more effectively. It is preferable to use a component selected from oxyethylene sorbitan, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monoisostearate, polyoxyethylene sorbitan tristearate, and polyoxyethylene sorbitan trioleate, and coconut oil fatty acid sorbitan It is more preferable to use a component selected from polyoxyethylene sorbitan monostearate and monostearate.
 成分D以外の非イオン性界面活性剤としてソルビタン脂肪酸エステル型非イオン性界面活性剤を使用する場合において、原液100質量%中の、ソルビタン脂肪酸エステル型非イオン性界面活性剤の含有量は、しっかりとした濃密な泡を形成する観点から、好ましくは0.05~5.0質量%であり、より好ましくは0.1~4.0質量%であり、さらに好ましくは0.1~3.0質量%である。上記含有量は、原液中に含まれる全てのソルビタン脂肪酸エステル型非イオン性界面活性剤の含有量の合計量である。 When a sorbitan fatty acid ester type nonionic surfactant is used as a nonionic surfactant other than the component D, the content of the sorbitan fatty acid ester type nonionic surfactant in 100% by mass of the stock solution is From the viewpoint of forming a dense foam, preferably 0.05 to 5.0% by mass, more preferably 0.1 to 4.0% by mass, and still more preferably 0.1 to 3.0%. It is mass%. The above content is the total content of the contents of all sorbitan fatty acid ester type nonionic surfactants contained in the stock solution.
 上記原液は、さらに、成分Eの多価アルコールを含有していることが好ましい。成分Eは、成分Aの析出抑制をより効果的に高めることができる。上記成分Eは、1種のみを用いてもよいし、2種以上を用いてもよい。 The stock solution preferably further contains a polyhydric alcohol of component E. Component E can more effectively suppress precipitation of component A. The said component E may use only 1 type, and may use 2 or more types.
 上記成分Eとしては、例えば、ソルビトール、マルチトール、グルコシルトレハロースなどの糖アルコール、エチレングリコール、ジエチレングリコール、トリエチレングリコール、プロピレングリコール、イソプレングリコール、ジプロピレングリコール、ポリエチレングリコール、1,3-ブチレングリコール(1,3-ブタンジオール)、1,2-ブタンジオール、1,2-ペンタンジオール、1,2-ヘキサンジオール、1,2-オクタンジオール、1,2-デカンジオール、グリセリン(1,2,3-プロパントリオール)、ジグリセリン、ポリグリセリン、ポリオキシエチレンメチルグルコシド、ポリオキシプロピレンメチルグルコシドなどが挙げられ、洗浄後の肌の突っ張り感を緩和できる観点や、泡もちを良好とする観点から、糖アルコールを含むことが好ましい。 As the component E, for example, sugar alcohols such as sorbitol, maltitol, glucosyltrehalose, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, isoprene glycol, dipropylene glycol, polyethylene glycol, 1,3-butylene glycol (1 (1, 3-butanediol), 1,2-butanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, glycerin (1,2,3-butanediol) Propanetriol), diglycerin, polyglycerin, polyoxyethylene methyl glucoside, polyoxypropylene methyl glucoside, etc., and from the viewpoint of being able to alleviate the feeling of skin firmness after washing, and from the viewpoint of making the lather good Et al, it is preferred to include a sugar alcohol.
 原液100質量%中の、成分Eの含有量は、成分Aの析出抑制をより効果的に高める観点から、好ましくは0.5~20.0質量%であり、より好ましくは1.0~15.0質量%であり、さらに好ましくは1.0~10.0質量%である。上記含有量は、原液中に含まれる全ての成分Eの含有量の合計量である。 The content of component E in 100% by mass of the stock solution is preferably 0.5 to 20.0% by mass, more preferably 1.0 to 15%, from the viewpoint of more effectively suppressing precipitation of component A. The content is 0.1% by mass, and more preferably 1.0 to 10.0% by mass. The content is the total of the content of all the components E contained in the stock solution.
 上記原液は、さらに、成分F1:キサンタンガム、及びグアーガムから選ばれる増粘性化合物や成分F2:ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース、及びヒドロキシプロピルセルロースから選ばれる増粘性化合物などの成分F:増粘性化合物を含有していることが好ましい。 The stock solution further contains a thickening compound selected from component F1: xanthan gum and guar gum; and a component F such as a thickening compound selected from component F2: hydroxypropyl methylcellulose, hydroxyethyl cellulose, and hydroxypropyl cellulose: thickening compound Is preferred.
 成分Fの増粘性化合物は、泡もちを良好とする効果がある。上記成分Fは、1種のみを用いてもよいし、2種以上を用いてもよいが、成分F1と成分F2を併用することが好ましい。 The thickening compound of component F has the effect of improving the foam resistance. Although the said component F may use only 1 type and may use 2 or more types, it is preferable to use the component F1 and the component F2 together.
 原液100質量%中の、成分F1の含有量は、泡もちを良好とする観点から、好ましくは0.01~0.5質量%であり、より好ましくは0.03~0.4質量%であり、さらに好ましくは0.05~0.3質量%である。上記含有量は、原液中に含まれる全ての成分F1の含有量の合計量である。 The content of the component F1 in 100% by mass of the stock solution is preferably 0.01 to 0.5% by mass, more preferably 0.03 to 0.4% by mass from the viewpoint of improving the foam resistance. And more preferably 0.05 to 0.3% by mass. The said content is a total amount of content of all the components F1 contained in a undiluted | stock solution.
 原液100質量%中の、成分F2の含有量は、泡もちを良好とする観点から、好ましくは0.01~0.5質量%であり、より好ましくは0.02~0.4質量%であり、さらに好ましくは0.03~0.2質量%である。上記含有量は、原液中に含まれる全ての成分F2の含有量の合計量である。 The content of the component F2 in 100% by mass of the stock solution is preferably 0.01 to 0.5% by mass, more preferably 0.02 to 0.4% by mass from the viewpoint of improving the foam resistance. It is more preferably 0.03 to 0.2% by mass. The said content is a total amount of content of all the components F2 contained in a undiluted | stock solution.
 原液は、特に限定されないが、上記成分A~F以外の成分(その他の成分)を含んでもよい。例えば、香料;シクロペンタシロキサン、ハイドロゲンジメチコン、カプリリルメチコン、メチルフェニルポリシロキサン、ジメチコン等のシリコーン油;フェノキシエタノール、オクトキシグリセリン、メチルパラベン等の防腐剤;メントール、メンチルグリセリルエーテル、カンファー、ペパーミント油等の冷感剤;グリチルリチン酸ジカリウム、グリチルリチン酸ステアリル等の抗炎症剤;シャクヤク、ボタンピ、ビワ、アロエ等の植物抽出エキス;殺菌剤;トコフェロール、ジブチルヒドロキシトルエン等の酸化防止剤;メトキシケイヒ酸オクチル、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸オクチル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、t-ブチルメトキシジベンゾイルメタン、オクチルトリアゾン、パラメトキシケイ皮酸2-エチルヘキシルなどの紫外線吸収剤;エデト酸塩等のキレート剤;アルブチン、アスコルビン酸等の美白剤;シリカ、タルク、ナイロンパウダー等の粉体などを含んでもよい。 The stock solution is not particularly limited, but may contain components other than the components A to F (other components). For example, perfumes; silicone oils such as cyclopentasiloxane, hydrogen dimethicone, caprylyl methicone, methylphenylpolysiloxane, dimethicone, etc. preservatives such as phenoxyethanol, octoxyglycerin, methyl paraben, etc. menthol, menthyl glyceryl ether, camphor, peppermint oil etc. Cooling agent; Anti-inflammatory agent such as dipotassium glycyrrhizinate and stearyl glycyrrhizinate; Extract of plant extract such as peony, peony, loquat, aloe, etc .; Bactericide; Antioxidant such as tocopherol, dibutyl hydroxytoluene; Benzylidene dioxo imidazolidine octyl propionate, diethyl aminohydroxy benzoyl benzoate, t-butyl methoxy dibenzoyl methane, octyl Riazon, ultraviolet absorbents such as 2-ethylhexyl p-methoxycinnamate; chelating agents such as edetate salts; arbutin, whitening agents such as ascorbic acid; silica, talc, may contain such powders such as nylon powder.
 殺菌剤としては、例えば、イソプロピルメチルフェノール、塩化ベンザルコニウム、ヒノキチオール、トリクロサン、グリチルリチン酸ジカリウム、及びサリチル酸等が挙げられる。なかでも、イソプロピルメチルフェノール、サリチル酸がより好ましく、サリチル酸がさらに好ましい。上記殺菌剤は、1種のみを用いてもよいし、2種以上を用いてもよい。 Examples of the microbicide include isopropylmethylphenol, benzalkonium chloride, hinokitiol, triclosan, dipotassium glycyrrhizinate, and salicylic acid. Among them, isopropylmethylphenol and salicylic acid are more preferable, and salicylic acid is more preferable. The said germicide may use only 1 type and may use 2 or more types.
 原液100質量%中の、殺菌剤の含有量は、好ましくは0.01質量%以上であり、より好ましくは0.05質量%以上であり、好ましくは2.0質量%以下であり、より好ましくは1.0質量%以下であり、更に好ましくは0.5質量%以下である。殺菌剤の含有量が上記下限以上であると、殺菌効果が効果的に得られる。また、安全性の観点から、殺菌剤の含有量は上記上限以下であることが好ましい。上記含有量は、原液中に含まれる全ての殺菌剤の含有量の合計量である。 The content of the bactericidal agent in 100% by mass of the stock solution is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, and preferably 2.0% by mass or less, more preferably Is 1.0% by mass or less, more preferably 0.5% by mass or less. A bactericidal effect is effectively acquired as content of a germicide is more than the above-mentioned minimum. Moreover, it is preferable that content of a germicide is below the said upper limit from a viewpoint of safety | security. The above content is the total of the content of all the germicides contained in the stock solution.
 本発明においては、原液中に殺菌剤を含有する場合、フォーム状皮膚洗浄料における濃密な泡の形成能が低下する場合があること、及び、この問題に対して、HLB9.0~13.0のポリエチレングリコール型非イオン性界面活性剤を併せて含有することで泡質を改善できることを新たに見出した。かかるメカニズムは不明であるが、ポリエチレングリコール型非イオン性界面活性剤はPEG鎖を有しており、エマルションの表面を被覆することで水和層を大きくする効果を有するため、乳化粒子をより安定化することができ、この結果、殺菌剤を加えた系においても、泡質を損なうことなく、より質感の良い泡を形成することが可能になったと考えられる。 In the present invention, when a bactericidal agent is contained in the stock solution, the ability to form a thick foam in the foam skin cleanser may be reduced, and HLB 9.0 to 13.0 is used for this problem. It has been newly found that the foam quality can be improved by additionally containing a polyethylene glycol type nonionic surfactant. Although the mechanism is unknown, the polyethylene glycol type nonionic surfactant has a PEG chain and has an effect of enlarging the hydration layer by coating the surface of the emulsion, so the emulsion particles are more stable. It can be considered that as a result, even in a system to which a bactericidal agent is added, it is possible to form a foam having a better texture without losing the foam quality.
 従って、原液中に殺菌剤を含有する場合においては、濃密な泡を形成する観点から、HLB9.0~13.0、好ましくはHLB9.5~12.0のポリエチレングリコール型非イオン性界面活性剤を併せて含有することが好ましい。HLB9.0~13.0のポリエチレングリコール型非イオン性界面活性剤は、HLB9.0~13.0の成分Dを含有してもよいし、成分D以外のHLB9.0~13.0のポリエチレングリコール型非イオン性界面活性剤をさらに含有してもよい。成分D以外のHLB9.0~13.0のポリエチレングリコール型非イオン性界面活性剤としては、例えば、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンヒマシ油などが挙げられる。上記HLB9.0~13.0のポリエチレングリコール型非イオン性界面活性剤は、1種のみを用いてもよいし、2種以上を用いてもよい。 Therefore, in the case of containing a bactericidal agent in the stock solution, a polyethylene glycol type nonionic surfactant of HLB 9.0 to 13.0, preferably HLB 9.5 to 12.0 from the viewpoint of forming a dense foam. Is preferably contained in combination. Polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 may contain component D of HLB 9.0 to 13.0, polyethylene of HLB 9.0 to 13.0 other than component D It may further contain a glycol type nonionic surfactant. Examples of polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 other than the component D include, for example, polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil and the like. The polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 may be used alone or in combination of two or more.
 原液中に殺菌剤を含有する場合において、原液100質量%中の、HLB9.0~13.0のポリエチレングリコール型非イオン性界面活性剤の含有量は、しっかりとした濃密な泡を形成する観点から、好ましくは0.3~1.5質量%であり、より好ましくは0.5~1.0質量%であり、さらに好ましくは0.5~0.8質量%である。上記含有量は、原液中に含まれる全てのHLB9.0~13.0のポリエチレングリコール型非イオン性界面活性剤の含有量の合計量である。 In the case where the stock solution contains a bactericidal agent, the content of the polyethylene glycol type nonionic surfactant of HLB 9.0 to 13.0 in 100% by mass of the stock solution forms a firm and dense foam. It is preferably 0.3 to 1.5% by mass, more preferably 0.5 to 1.0% by mass, and still more preferably 0.5 to 0.8% by mass. The above content is the total of the content of polyethylene glycol type nonionic surfactant of all HLBs 9.0 to 13.0 contained in the stock solution.
 噴射剤としては、公知の噴射剤が挙げられ、例えば、空気、窒素、亜酸化窒素等のガス(特に、圧縮ガス);液化石油ガス(LPG:Liquefied Petroleum Gas)、ジメチルエーテル(DME:Dimethyl ether)、イソペンタン、フロロカーボン等の液化ガスなどが挙げられる。噴射剤は、1種のみを用いてもよいし、2種以上を用いてもよい。 Examples of the propellant include known propellants, for example, gases such as air, nitrogen and nitrous oxide (especially compressed gas); liquefied petroleum gas (LPG: liquefied petroleum gas), dimethyl ether (DME: dimethyl ether) And liquefied gases such as isopentane and fluorocarbon. The propellant may be used alone or in combination of two or more.
 エアゾール容器としては、公知慣用の容器が挙げられ、特に限定されない。 As an aerosol container, a well-known and usual container is mentioned, It does not specifically limit.
 エアゾール容器内において、原液と噴射剤の合計量100質量%中の、噴射剤の含有量は、吐出物の液化を防止する観点から、好ましくは2.0~20.0質量%であり、より好ましくは、3.0~15.0質量%である。2種類以上の噴射剤を使用する場合、前記「噴射剤の含有量」は、噴射剤を構成する個々の成分の合計量を意味する。 In the aerosol container, the content of the propellant in the total amount of 100% by mass of the undiluted solution and the propellant is preferably 2.0 to 20.0% by mass from the viewpoint of preventing the liquefaction of the discharge. Preferably, it is 3.0 to 15.0% by mass. When two or more types of propellants are used, the "propellant content" means the total amount of individual components constituting the propellant.
 本発明のフォーム状皮膚洗浄料は既知の方法により製造することができる。例えば、原液をエアゾール容器に充填し、エアゾール用バルブにより容器をクリンチした後、規定量の噴射剤をステムから容器内へ充填し、噴射ボタンを装着する、という製造方法を例示することができる。 The foamy skin cleanser of the present invention can be produced by known methods. For example, it is possible to exemplify a manufacturing method in which an undiluted solution is filled in an aerosol container, the container is clinched by an aerosol valve, and then a specified amount of propellant is filled from the stem into the container and the injection button is attached.
 本発明のフォーム状皮膚洗浄料は、顔等の皮膚を洗浄するために用いられる皮膚洗浄料である。本発明のフォーム状皮膚洗浄料としては、洗顔料、ハンドソープ、ボディソープや頭皮の洗浄料等が挙げられる。本発明のフォーム状皮膚洗浄料は、洗浄後の肌のつっぱり感及び高級脂肪酸の析出を抑制するものであるので、特に洗顔料等、デリケートな部位の洗浄料に適している。 The foam skin cleanser of the present invention is a skin cleanser used to clean skin such as face. The foam skin cleanser of the present invention includes a cleanser, hand soap, body soap, scalp cleanser and the like. The foam skin cleanser according to the present invention suppresses the feeling of skin firmness after washing and the precipitation of higher fatty acids, and therefore is particularly suitable for use as a cleanser for delicate areas such as face cleansers.
 以下に、本発明を実施例等に基づいてさらに詳細に説明するが、本発明はかかる実施例のみに限定されるものではない。 Hereinafter, the present invention will be described in more detail based on examples and the like, but the present invention is not limited to such examples.
実施例1~76及び比較例1~3
 表1~12に記した組成からなる原液95質量部をエアゾール容器(φ35mm×105mm、アルミ缶、容器満注量:91ml)に充填し、エアゾールバルブを該容器にクリンチした後、噴射剤として液化石油ガス(LPG)5質量部をステムより充填し、適したスパウトを装着し、フォーム状皮膚洗浄料を得た。なお、エアゾール容器に充填した原液と噴射剤の合計量は50gである。
Examples 1 to 76 and Comparative Examples 1 to 3
95 parts by mass of the stock solution having the composition described in Tables 1 to 12 is filled in an aerosol container (φ 35 mm × 105 mm, aluminum can, container full filling amount: 91 ml) and after clinching the aerosol valve into the container, it is liquefied as a propellant 5 parts by mass of petroleum gas (LPG) was filled from the stem and equipped with a suitable spout to obtain a foamy skin cleanser. The total amount of the undiluted solution and the propellant charged in the aerosol container is 50 g.
 実施例、比較例、処方例における各原料の詳細は次の通りである。なお、表1~12に記載の量は特記しない限り「質量%」を表し、商品の量ではなく、各成分の量(有効成分の量)である。 The detail of each raw material in an Example, a comparative example, and a formulation example is as follows. The amounts described in Tables 1 to 12 represent “% by mass” unless specifically stated, and are not the amount of the product but the amount of each component (the amount of the active ingredient).
ミリスチン酸:EDENOR C14-99(Emery Oleochemicals社製)
パルミチン酸:EDENOR C14-99(Emery Oleochemicals社製)
ミリスチン酸イソプロピル:エキセパールIPM(花王社製)
イソノナン酸イソノニル:サラコス99(日清オイリオグループ社製)
パルミチン酸2-エチルヘキシル:コーヨーPOC(交洋ファインケミカル社製)
2-エチルヘキサン酸セチル:サラコス816T(日清オイリオグループ社製)
ミリスチン酸オクチルドデシル:エキセパールOD-M(花王社製)
モノステアリン酸ポリエチレングリコール:エマノーン3199VB(花王社製:酸化エチレンの平均付加モル数150)
モノイソステアリン酸ポリエチレングリコール:EMALEX PEIS-12EX(日本エマルジョン社製:酸化エチレンの平均付加モル数12)
ジステアリン酸ポリエチレングリコール:エマノーン3299RV(花王社製:酸化エチレンの平均付加モル数250)
ジイソステアリン酸ポリエチレングリコール:EMALEX 6000di-ISEX(日本エマルジョン社製:酸化エチレンの平均付加モル数12)
ジプロピレングリコール:ジプロピレングリコールDPG-FC(旭硝子社製)
ポリエチレングリコール:PEG-1500(三洋化成工業社製:数平均分子量1500)
ソルビトール:ソルビットL-70(三菱商事フードテック社製)
キサンタンガム:エコーガムT(DSP五協フード&ケミカル社製)
グアーガム:スーパーゲルCSA200/50(三晶社製)
ヒドロキシプロピルセルロース:HPC-H(日本曹達社製)
ヒドロキシプロピルメチルセルロース:メトローズ60SH-4000(信越化学工業社製)
ヒドロキシエチルセルロール:HEC CF-W(住友精化社製)
トリエタノールアミン:TEA-99(ジャパンケムテック社製)
ヤシ油脂肪酸ソルビタン:レオドールスーパーSP-L10(花王社製)
モノステアリン酸ポリオキシエチレンソルビタン:レオドールTW-S120V(花王社製:酸化エチレンの平均付加モル数20)
ヘキサ(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)ジペンタエリスリチル:コスモール168ARV(日清オイリオグループ社製)
テトラ(ヒドロキシステアリン酸/イソステアリン酸)ジペンタエリスリチル:コスモール168EV(日清オイリオグループ社製)
ヘキサヒドロキシステアリン酸ジペンタエリスリチル:コスモール168M(日清オイリオ社製)
マルチトール:LYCASIN75/77(ROQUETTE社製)
グルコシルトレハロース:Tornare(林原社製)
モノステアリン酸ポリエチレングリコール1:エマノーン3199VB(花王社製:酸化エチレンの平均付加モル数150、HLB:19.4)
ポリオキシエチレン硬化ヒマシ油:ブラウノンRCW-20(青木油脂社製、酸化エチレンの平均付加モル数20、HLB:9.7)
モノステアリン酸ポリエチレングリコール2:NIKKOL YMS-10V(日光ケミカルズ社製:酸化エチレンの平均付加モル数10、HLB:11.0)
Myristic acid: EDENOR C14-99 (manufactured by Emery Oleochemicals)
Palmitic acid: EDENOR C14-99 (manufactured by Emery Oleochemicals)
Isopropyl myristate: Excepearl IPM (manufactured by Kao Corporation)
Isononyl isononanoate: Saracos 99 (manufactured by Nisshin Oillio Group, Inc.)
2-ethylhexyl palmitate: KOYO POC (manufactured by Kyosho Fine Chemical Co., Ltd.)
Cetyl 2-ethylhexanoate: Saracos 816 T (manufactured by Nisshin Oillio Group, Inc.)
Octyl dodecyl myristate: Excepearl OD-M (manufactured by Kao Corporation)
Polyethylene glycol monostearate: Emanol 3199 VB (manufactured by Kao Corporation: average number of moles of ethylene oxide added: 150)
Polyethylene glycol monoisostearate: EMALEX PEIS-12EX (manufactured by Nippon Emulsion Co., Ltd .: average addition mole number of ethylene oxide: 12)
Polyethylene glycol distearate: Emamino 3299 RV (Kao Co., Ltd .: average added mole number of ethylene oxide 250)
Polyethylene glycol diisostearate: EMALEX 6000 di-ISEX (manufactured by Nippon Emulsion Co., Ltd .: average addition mole number of ethylene oxide: 12)
Dipropylene glycol: Dipropylene glycol DPG-FC (manufactured by Asahi Glass Co., Ltd.)
Polyethylene glycol: PEG-1500 (manufactured by Sanyo Chemical Industries, Ltd .: number average molecular weight 1500)
Sorbitol: Sorbit L-70 (made by Mitsubishi Corporation Foodtech)
Xanthan gum: Echo gum T (made by DSP Gokyo Food & Chemical Co.)
Guar gum: Supergel CSA 200/50 (manufactured by Sanyo Seiyaku Co., Ltd.)
Hydroxypropyl cellulose: HPC-H (manufactured by Nippon Soda Co., Ltd.)
Hydroxypropyl methylcellulose: Metrose 60SH-4000 (Shin-Etsu Chemical Co., Ltd.)
Hydroxyethyl cellulose: HEC CF-W (manufactured by Sumitomo Seika Chemicals Co., Ltd.)
Triethanolamine: TEA-99 (manufactured by Japan Chemtech)
Coconut oil fatty acid sorbitan: Leodor Super SP-L10 (made by Kao Corporation)
Polyoxyethylene sorbitan monostearate: Reodor TW-S 120 V (manufactured by Kao Corporation: average number of moles of ethylene oxide added: 20)
Hexa (hydroxystearic acid / stearic acid / rosin acid) dipentaerythrityl: Cosmall 168 ARV (manufactured by Nisshin Oillio Group, Inc.)
Tetra (hydroxystearic acid / isostearic acid) dipentaerythrityl: Cosmall 168 EV (manufactured by Nisshin Oillio Group, Inc.)
Dipentaerythrythyl hexahydroxystearate: Cosmall 168M (manufactured by Nisshin Oillio Co., Ltd.)
Maltitol: LYCASIN 75/77 (made by ROQUETTE)
Glucosyl Trehalose: Tornare (manufactured by Hayashibara)
Polyethylene glycol monostearate 1: Emmon 3199 VB (manufactured by Kao Corporation: average added mole number of ethylene oxide 150, HLB: 19.4)
Polyoxyethylene hydrogenated castor oil: Braunone RCW-20 (manufactured by Aoki Yushi Co., Ltd., average added mole number of ethylene oxide 20, HLB: 9.7)
Polyethylene glycol monostearate 2: NIKKOL YMS-10V (manufactured by Nikko Chemicals Co., Ltd .: average addition mole number of ethylene oxide: 10, HLB: 11.0)
[高級脂肪酸の析出抑制]
 各実施例、及び各比較例で得られた原液と噴射剤とを透明耐圧ビンに充填し、2℃条件下の恒温槽中に保管した。1週間後の原液の状態を目視観察し、析出の有無を評価した。結果を表1~4及び8~11に示す。なお、実施例21~40、71~76については、表に記載することを省略したが、いずれの評価も○(良好)であった。
○(良好):原液中に結晶やゲル状物質の析出が確認されない
△(不十分):詰まりに影響を及ぼす程度では無いが、ゲル状物質の析出が確認された
×(不良):詰まりの懸念を引き起こすと想定される大きさ、量の結晶の析出物が確認された
[Precipitate suppression of higher fatty acids]
The undiluted | stock solution and propellant which were obtained by each Example and each comparative example were filled with the transparent pressure | voltage resistant bottle, and were stored in the thermostat at 2 degreeC conditions. The state of the stock solution after one week was visually observed to evaluate the presence or absence of precipitation. The results are shown in Tables 1 to 4 and 8 to 11. In Examples 21 to 40 and 71 to 76, the description in the table was omitted, but all evaluations were also ○ (good).
○ (Good): Precipitation of crystals or gel-like substance not observed in the stock solution Δ (Insufficient): Not enough to affect clogging, Precipitation of gel-like substance was confirmed × (Defective): Blocking Crystal deposits of the size and amount expected to cause concern were identified
[洗浄力]
 ウレタン製の白色の凹凸表面上に、市販のリキッドファンデーションを直径3cm程度塗り広げ、その上に各実施例及び各比較例のフォーム状皮膚洗浄料の泡を0.5秒間吐出させ、20秒間手の平で泡を円状に広げるようにこすり、40℃の温水で洗い流した後の汚れ落ち具合を目視評価した。なお、目視評価は、温水で洗い流しただけのメイク汚れ状態のものと対比した。結果を表1~11に示す。なお、実施例71~76については、表に記載することを省略したが、いずれの評価も◎(非常に良好)であった。
◎(非常に良好):汚れが完全に落ちている状態
○(良好):汚れがほぼ落ちているが、僅かに汚れ落ちが不十分な状態
△(不十分):僅かに汚れ落ちが確認されるものの、汚れがほぼ残っている状態
×(不良):汚れが完全に残っている状態(温水で流しただけの状態と同程度)
[Washing power]
A commercially available liquid foundation is spread about 3 cm in diameter on a white uneven surface made of urethane, and the foam of the foam skin cleansing agent of each example and each comparative example is discharged for 0.5 seconds, and a palm for 20 seconds. The foam was rubbed so as to spread in a circular shape, and the degree of soiling after being rinsed with warm water at 40 ° C. was visually evaluated. In addition, visual evaluation was contrasted with the thing of the makeup stain state which was washed away with warm water. The results are shown in Tables 1-11. In Examples 71 to 76, the description in the table was omitted, but all evaluations were ◎ (very good).
((Very good): Completely soiled condition ((good): Almost soiled condition, but slightly soiled condition not enough Δ (Insufficient): Slightly soiled condition confirmed However, the condition in which the contamination is almost left x (defective): the condition in which the contamination is completely left (about the same as the condition just flowed with warm water)
 キムタオル(4つ折りタイプ:日本製紙クレシア社製)の上に、各実施例及び各比較例のフォーム状皮膚洗浄料の泡を1秒間、ドーム状になるように吐出した。次いで、該ドーム状に吐出した泡の上端から20cm離れた距離から、ポンプ容器(噴霧吐出量:0.5mL/1プッシュ)に充填した精製水を2プッシュ、泡全体に噴霧し、30秒後、指先で泡表面を軽く押し、下記1点から4点の評価点に従って、実施例1~20、比較例1、2については「泡弾力」について、また、実施例21~76、比較例3については「泡弾力」並びに「泡質(泡の濃密さ)」について官能評価を行った。なお、評価は、評価パネル10名で行い、最も人数の多く得られた評価点(スコア)の結果を各試料の成績とした。結果を表1~12に示す。 The foam-like skin cleanser foam of each example and each comparative example was discharged onto a Kim towel (quadruple type: Nippon Paper Cress Co., Ltd.) for 1 second in a dome shape. Then, from the distance of 20 cm away from the top end of the dome-shaped foam, 2 push the purified water filled in the pump container (spray discharge amount: 0.5 mL / 1 push), spray the whole foam, and after 30 seconds Lightly press the surface of the foam with a fingertip, and according to the evaluation points 1 to 4 below, Examples 1 to 20, Comparative Examples 1 and 2 for "foam elasticity", and Examples 21 to 76, Comparative Example 3 The sensory evaluation was carried out for “foam elasticity” and “foam quality (density of foam)”. In addition, evaluation was performed by 10 evaluation panels, and the result of the evaluation point (score) obtained most by the number of people was made into the result of each sample. The results are shown in Tables 1-12.
[泡弾力]
◎(評価点4:非常に良好):指先で容易に泡が崩壊せず、指先を押し返すような強い弾力性を感じる
○(評価点3:良好):指先で容易に泡が崩壊せず、指先を押し返すような弾力性を感じる
△(評価点2:不十分):指先を押し返すような弾力性を若干感じるが、指先で泡が崩壊する
×(評価点1:不良):指先で容易に泡が崩壊し、指先を押し返すような弾力性を全く感じない
[Foam elasticity]
((4 points: very good): The bubbles do not easily collapse at the fingertips, and a strong elasticity such as pushing back the fingertips is felt ○ (Evaluation points 3: good): The bubbles do not easily collapse at the fingertips, Feel the elasticity like pushing back the finger ((Evaluation point 2: Insufficient): Feel some elasticity like pushing back the finger, but the bubble collapses at the finger x (Evaluation point 1: Poor): Easily with the finger tip Bubble collapses and does not feel elasticity like pushing back the finger at all
[泡質(泡の濃密さ)]
◎(評価点4:非常に良好):均一且つきめ細かな気泡を有しており、非常に濃密な泡が形成されている
○(評価点3:良好):不均一ではあるがきめ細かな気泡を有しており、濃密な泡が形成されている
△(評価点2:不十分):大きな気泡が混在しており、濃密な泡の形成に劣る
×(評価点1:不良):濃密な泡が全く形成されていない(ガスが分離した状態で吐出されている)
[Foam quality (density of foam)]
((Evaluation point 4: very good): uniform and fine bubbles were formed, and very dense bubbles were formed ○ (evaluation point 3: good): non-uniform but fine bubbles Having a dense foam is formed Δ (Evaluation point 2: Insufficient): Large bubbles are mixed and inferior to the formation of a dense foam × (Evaluation point 1: Poor): A dense foam Is not formed at all (gas is discharged in the separated state)
[泡持ち]
 キムタオル(4つ折りタイプ:日本製紙クレシア社製)の上に、各実施例及び各比較例のフォーム状皮膚洗浄料の泡を1秒間、ドーム状になるように吐出した。次いで、該ドーム状に吐出した泡の上端から20cm離れた距離から、ポンプ容器(噴霧吐出量:0.5mL/1プッシュ)に充填した精製水を2プッシュ、泡全体に噴霧し、30秒後の「泡形状」、「泡のきめ細やかさ」について目視確認を行い、下記1点から4点の評価点に従って「泡もち」の評価を行った。なお、評価は、評価パネル10名で行い、最も人数の多く得られた評価点(スコア)の結果を各試料の成績とした。結果を表1~12に示す。
◎(評価点4:非常に良好):吐出直後の泡形状が維持され、泡表面のきめも細やかである
○(評価点3:良好):泡表面のきめがやや粗くなっているが、吐出直後の泡形状は維持されている
△(評価点2:不十分):泡表面に大きな気泡が認められ、吐出直後の泡形状が若干崩れ始めている
×(評価点1:不良):吐出直後の泡形状が明らかに崩壊している
[Bubbling]
The foam-like skin cleanser foam of each example and each comparative example was discharged onto a Kim towel (quadruple type: Nippon Paper Cress Co., Ltd.) for 1 second in a dome shape. Then, from the distance of 20 cm away from the top end of the dome-shaped foam, 2 push the purified water filled in the pump container (spray discharge amount: 0.5 mL / 1 push), spray the whole foam, and after 30 seconds Visual confirmation was carried out on the “foam shape” and “fineness of the foam”, and the “foam glutiness” was evaluated according to the following 1 to 4 evaluation points. In addition, evaluation was performed by 10 evaluation panels, and the result of the evaluation point (score) obtained most by the number of people was made into the result of each sample. The results are shown in Tables 1-12.
((Evaluation point 4: very good): The foam shape immediately after discharge is maintained, and the texture of the foam surface is fine ○ (Evaluation point 3: good): The foam surface texture is slightly rough, but discharge The foam shape immediately after is maintained △ (Evaluation point 2: Insufficient): Large air bubbles are observed on the foam surface, and the foam shape immediately after discharge is slightly broken x (Evaluation point 1: Poor): Immediately after discharge The foam shape is clearly collapsed
[洗浄後の肌状態(つっぱり感のなさ)]
 40℃の温水で顔を洗い流してもらった後、各実施例及び各比較例のフォーム状皮膚洗浄料を用いて実際に洗顔操作を行ってもらい、頬部に泡をあて、円を描くように延び広げ、再び40℃の温水で洗い流し、タオルドライ後の感触(肌残り感)について官能評価を行い、下記1点から4点の評価点に従ってスコア付けをした。なお、評価は、評価パネル10名で行い、最も人数の多く得られた評価点(スコア)の結果を各試料の成績とした。結果を表1~12に示す。
◎(評価点4:非常に良好):しっとりとした残り感が非常に高い
○(評価点3:良好):しっとりとした残り感が高い
△(評価点2:不十分):しっとりとした残り感が少なく、つっぱり感が高い
×(評価点1:不良):しっとりとした残り感が全くなく、つっぱり感が非常に高い
[Skin condition after washing (not feeling tight)]
After having the face washed away with warm water at 40 ° C, the face-washing operation is actually performed using the foam skin cleansing agent of each example and each comparative example, and bubbles are applied to the cheek to draw a circle. It was spread and washed again with warm water at 40 ° C., and the feel after towel drying (feeling of remaining skin) was evaluated sensoryally, and scored according to the following 1 to 4 points. In addition, evaluation was performed by 10 evaluation panels, and the result of the evaluation point (score) obtained most by the number of people was made into the result of each sample. The results are shown in Tables 1-12.
((Score 4: very good): very moist residual feeling ((score 3: good): moist moist residual feeling 評 価 (score 2: insufficient): moist remaining Less feeling, high feeling of tightness x (score 1: poor): There is no feeling of moist and left feeling at all, feeling of tightness is very high
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000012
 表1~12より、成分A、成分B、成分C、及び成分Dを含有する実施例1~76のフォーム状皮膚洗浄料は、高級脂肪酸の析出抑制、洗浄力、泡弾力、泡持ち、洗浄後の肌状態(つっぱり感のなさ)のいずれについても優れるものであった。一方で、成分Bを含有しない比較例1、3や、成分Dを含有しない比較例2のフォーム状皮膚洗浄料では、高級脂肪酸の析出が見られた。また、実施例21~38、41~64と、実施例39、40、65との対比から、室温で固形状の脂肪酸エステル油及びソルビタン脂肪酸エステル型非イオン性界面活性剤を含有するフォーム状皮膚洗浄料では、濃密な泡を形成できていることが分かる。また、実施例71~76に示すように、殺菌剤を含有する系においては、HLB9.0~13.0のポリエチレングリコール型非イオン性界面活性剤を含有する実施例74、75の泡質が好ましいことが分かる。 From Tables 1 to 12, the foamy skin cleansers of Examples 1 to 76 containing Component A, Component B, Component C, and Component D have suppression of precipitation of higher fatty acids, detergency, foam elasticity, foam retention, cleansing It was excellent about any of the skin condition (the lack of a feeling of tension) after. On the other hand, in Comparative Examples 1 and 3 which do not contain Component B, and in the foam skin cleansing agent of Comparative Example 2 which does not contain Component D, precipitation of higher fatty acids was observed. Further, as compared with Examples 21 to 38, 41 to 64 and Examples 39, 40, 65, foamy skin containing fatty acid ester oil and sorbitan fatty acid ester type nonionic surfactant which are solid at room temperature It can be seen that the cleaning agent can form a dense foam. In addition, as shown in Examples 71 to 76, in the systems containing a bactericide, the foams of Examples 74 and 75 containing polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 have the same properties as those of Examples 74 and 75. It turns out that it is preferable.
 以下、本発明に係るフォーム状皮膚洗浄料の処方例を示す。なお、配合量は「質量%」である。 Hereinafter, formulation examples of the foamy skin cleanser according to the present invention will be shown. In addition, a compounding quantity is "mass%."
 処方例1:
(原液)
ミリスチン酸                       2.00
パルミチン酸                       1.00
ステアリン酸                       1.00
トリエタノールアミン                   2.90
1,3-ブチレングリコール                2.00
ポリエチレングリコール                  2.00
キサンタンガム                      0.15
ヒドロキシプロピルメチルセルロース            0.05
アジピン酸ジイソプロピル※1               1.00
ヘキサ(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)ジペンタエリスリチル
                             1.00
ヤシ油脂肪酸ソルビタン                  1.00
モノステアリン酸ポリオキシエチレン(20)ソルビタン   1.50
モノステアリン酸ポリエチレングリコール          1.00
ソルビトール                       2.00
精製水                           残 部
 合計                        100.00
 
(噴射剤)
液化石油ガス(LPG)                100.00
 合計                        100.00
 
原液                          95.00
噴射剤                          5.00
 合計                        100.00
※1)アジピン酸ジイソプロピル:マットルーブDIA(成和化成社製)
Prescription example 1:
(Stock solution)
Myristic acid 2.00
Palmitic acid 1.00
Stearic acid 1.00
Triethanolamine 2.90
1,3-butylene glycol 2.00
Polyethylene glycol 2.00
Xanthan gum 0.15
Hydroxypropyl methylcellulose 0.05
Diisopropyl adipate * 1 1.00
Hexa (hydroxystearic acid / stearic acid / rosin acid) dipentaerythrityl 1.00
Coconut oil fatty acid sorbitan 1.00
Polyoxyethylene (20) sorbitan monostearate 1.50
Polyethylene glycol monostearate 1.00
Sorbitol 2.00
Refined water Total 100.00

(Propellant)
Liquefied petroleum gas (LPG) 100.00
100.00 in total

Undiluted solution 95.00
Propellant 5.00
100.00 in total
* 1) Diisopropyl adipate: Matte Lube DIA (manufactured by Seiwa Kasei)
 処方例2:
(原液)
ミリスチン酸                       3.00
トリエタノールアミン                   2.35
ジプロピレングリコール                  4.00
濃グリセリン                       1.00
キサンタンガム                      0.15
ヒドロキシプロピルセルロース               0.10
アジピン酸ジイソブチル※2                1.00
テトラ(ヒドロキシステアリン酸/イソステアリン酸)ジペンタエリスリチル
                             1.00
ヤシ油脂肪酸ソルビタン                  1.00
モノステアリン酸ポリオキシエチレン(20)ソルビタン   0.75
ジステアリン酸ポリエチレングリコール           0.50
ソルビトール                       2.00
精製水                           残 部
 合計                        100.00
 
(噴射剤)
液化石油ガス(LPG)                100.00
 合計                        100.00
 
原液                          96.00
噴射剤                          4.00
 合計                        100.00
※2)アジピン酸ジイソブチル:マットルーブDIBA(成和化成社製)
Prescription example 2:
(Stock solution)
Myristic acid 3.00
Triethanolamine 2.35
Dipropylene glycol 4.00
Concentrated glycerin 1.00
Xanthan gum 0.15
Hydroxypropyl cellulose 0.10
Diisobutyl adipate * 2 1.00
Tetra (hydroxystearic acid / isostearic acid) dipentaerythrityl 1.00
Coconut oil fatty acid sorbitan 1.00
Polyoxyethylene (20) sorbitan monostearate 0.75
Polyethylene glycol distearate 0.50
Sorbitol 2.00
Refined water Total 100.00

(Propellant)
Liquefied petroleum gas (LPG) 100.00
100.00 in total

Undiluted solution 96.00
Propellant 4.00
100.00 in total
* 2) Diisobutyl adipate: Matte Lube DIBA (made by Seiwa Kasei)
 処方例3:
(原液)
ミリスチン酸                       3.00
パルミチン酸                       1.00
トリエタノールアミン                   3.05
ジプロピレングリコール                  4.00
キサンタンガム                      0.15
ヒドロキシエチルセルロース                0.10
ミリスチン酸イソプロピル                 1.00
ヘキサヒドロキシステアリン酸ジペンタエリスリチル     1.00
ヤシ油脂肪酸ソルビタン                  0.50
モノステアリン酸ポリオキシエチレン(20)ソルビタン   0.50
ジイソステアリン酸ポリエチレングリコール         0.50
マルチトール                       2.00
精製水                           残 部
 合計                        100.00
 
(噴射剤)
液化石油ガス(LPG)                100.00
 合計                        100.00
 
原液                          94.00
噴射剤                          6.00
 合計                        100.00
Prescription example 3:
(Stock solution)
Myristic acid 3.00
Palmitic acid 1.00
Triethanolamine 3.05
Dipropylene glycol 4.00
Xanthan gum 0.15
Hydroxyethyl cellulose 0.10
Isopropyl myristate 1.00
Hexahydroxystearate dipentaerythrityl 1.00
Coconut oil fatty acid sorbitan 0.50
Polyoxyethylene (20) sorbitan monostearate 0.50
Polyethylene glycol diisostearate 0.50
Maltitol 2.00
Refined water Total 100.00

(Propellant)
Liquefied petroleum gas (LPG) 100.00
100.00 in total

Undiluted solution 94.00
Propellant 6.00
100.00 in total
 本発明のフォーム状皮膚洗浄料は、顔、手、身体、頭皮や毛髪用の洗浄料等に使用することができる。 The foamy skin cleanser of the present invention can be used as a cleanser for face, hands, body, scalp and hair.

Claims (17)

  1.  原液と噴射剤とがエアゾール容器に充填されたフォーム状皮膚洗浄料であって、前記原液が、下記成分A、成分B、成分C、及び成分Dを含有することを特徴とするフォーム状皮膚洗浄料。
    成分A:高級脂肪酸及び/又はその塩
    成分B:室温で液状の脂肪酸エステル油
    成分C:水
    成分D:ポリエチレングリコール脂肪酸エステル型非イオン性界面活性剤
    An undiluted solution and a propellant are foamy skin cleansing agents filled in an aerosol container, and the undiluted solution contains the following ingredient A, ingredient B, ingredient C, and ingredient D. Foamy skin cleansing characterized by the above-mentioned Fee.
    Component A: Higher fatty acid and / or salt thereof Component B: Fatty acid ester oil component liquid at room temperature Component C: Water component D: Polyethylene glycol fatty acid ester type nonionic surfactant
  2.  前記成分Bが、直鎖脂肪酸と分岐低級アルコールとのエステル油、直鎖脂肪酸と分岐高級アルコールとのエステル油、分岐脂肪酸と直鎖高級アルコールとのエステル油、分岐脂肪酸と分岐高級アルコールとのエステル油、及び二塩基酸のエステル油から選ばれる成分を含む、請求項1に記載のフォーム状皮膚洗浄料。 Component B is an ester oil of a linear fatty acid and a branched lower alcohol, an ester oil of a linear fatty acid and a branched higher alcohol, an ester oil of a branched fatty acid and a linear higher alcohol, an ester of a branched fatty acid and a branched higher alcohol The foamy skin cleanser according to claim 1, comprising a component selected from an oil and an ester oil of a dibasic acid.
  3.  前記成分Bが、ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、パルミチン酸エチルヘキシル、エチルヘキサン酸セチル、イソノナン酸イソノニル、アジピン酸ジイソブチル、及びアジピン酸ジイソプロピルから選ばれる成分を含むことを特徴とする、請求項1又は2に記載のフォーム状皮膚洗浄料。 The component B is characterized in that it contains a component selected from isopropyl myristate, octyldodecyl myristate, ethylhexyl palmitate, cetyl ethylhexanoate, isononyl isononanoate, diisobutyl adipate, and diisopropyl adipate. Or the foamy skin cleanser as described in 2.
  4.  前記成分Dが、モノステアリン酸ポリエチレングリコール、モノイソステアリン酸ポリエチレングリコール、ジステアリン酸ポリエチレングリコール、ジイソステアリン酸ポリエチレングリコール、及びラウリン酸ポリエチレングリコールから選ばれる成分を含むことを特徴とする、請求項1~3のいずれか一項に記載のフォーム状皮膚洗浄料。 4. The composition according to claim 1, wherein said component D comprises a component selected from polyethylene glycol monostearate, polyethylene glycol monostearate, polyethylene glycol distearate, polyethylene glycol diisostearate, and polyethylene glycol laurate. The foam skin cleanser according to any one of the preceding claims.
  5.  前記原液が、さらに、下記成分Eを含有する、請求項1~4のいずれか一項に記載のフォーム状皮膚洗浄料。
    成分E:多価アルコール
    The foamy skin cleanser according to any one of claims 1 to 4, wherein the stock solution further comprises the following component E:
    Ingredient E: Polyhydric alcohol
  6.  前記成分Eが、糖アルコールを含む、請求項5に記載のフォーム状皮膚洗浄料。 The foamy skin cleanser according to claim 5, wherein the component E comprises a sugar alcohol.
  7.  前記原液が、さらに、下記成分Fを含有する、請求項1~6のいずれか一項に記載のフォーム状皮膚洗浄料。
    成分F:増粘性化合物
    The foam skin cleanser according to any one of claims 1 to 6, wherein the stock solution further comprises the following component F:
    Component F: Thickening compound
  8.  前記成分Fが、下記成分F1及び/又は下記成分F2を含むことを特徴とする、請求項7に記載のフォーム状皮膚洗浄料。
    成分F1:キサンタンガム、及びグアーガムから選ばれる増粘性化合物
    成分F2:ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース、及びヒドロキシプロピルセルロースから選ばれる増粘性化合物
    The foamy skin cleanser according to claim 7, wherein the component F comprises the following component F1 and / or the following component F2.
    Component F1: Thickening compound selected from xanthan gum and guar gum Component F2: Thickening compound selected from hydroxypropyl methylcellulose, hydroxyethyl cellulose, and hydroxypropyl cellulose
  9.  前記原液が、さらに、室温で固形状の脂肪酸エステル油を含有する、請求項1~8のいずれか一項に記載のフォーム状皮膚洗浄料。 The foamy skin cleanser according to any one of claims 1 to 8, wherein the stock solution further contains a fatty acid ester oil which is solid at room temperature.
  10.  前記室温で固形状の脂肪酸エステル油が、ヘキサ(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)ジペンタエリスリチル、テトラ(ヒドロキシステアリン酸/イソステアリン酸)ジペンタエリスリチル、及びヘキサヒドロキシステアリン酸ジペンタエリスリチルから選ばれる成分を含むことを特徴とする、請求項9に記載のフォーム状皮膚洗浄料。 The fatty acid ester oil which is solid at room temperature contains an ingredient selected from hexa (hydroxystearic acid / stearic acid / rosinic acid) dipentaerythrityl, tetra (hydroxystearic acid / isostearic acid) dipentaerythrityl, and dipentaerythrityl hexahydroxystearate. The foam skin cleanser according to claim 9, characterized in that.
  11.  前記原液が、さらに、ソルビタン脂肪酸エステル型非イオン性界面活性剤を含有する、請求項1~10のいずれか一項に記載のフォーム状皮膚洗浄料。 The foamy skin cleanser according to any one of claims 1 to 10, wherein the stock solution further contains a sorbitan fatty acid ester type nonionic surfactant.
  12.  前記ソルビタン脂肪酸エステル型非イオン性界面活性剤が、ヤシ油脂肪酸ソルビタン、パルミチン酸ソルビタン、及びモノステアリン酸ポリオキシエチレンソルビタンから選ばれる成分を含むことを特徴とする、請求項11に記載のフォーム状皮膚洗浄料。 The foam according to claim 11, wherein the sorbitan fatty acid ester type nonionic surfactant comprises a component selected from coconut oil fatty acid sorbitan, sorbitan palmitate, and polyoxyethylene sorbitan monostearate. Skin cleansing agent.
  13.  前記原液が、さらに、殺菌剤を含有する、請求項1~12のいずれか一項に記載のフォーム状皮膚洗浄料。 The foamy skin cleanser according to any one of claims 1 to 12, wherein the stock solution further contains a bactericide.
  14.  前記殺菌剤が、イソプロピルメチルフェノール、塩化ベンザルコニウム、ヒノキチオール、トリクロサン、グリチルリチン酸ジカリウム、及びサリチル酸から選ばれる成分を含むことを特徴とする、請求項13に記載のフォーム状皮膚洗浄料。 The foam skin cleansing agent according to claim 13, wherein the bactericidal agent comprises a component selected from isopropylmethylphenol, benzalkonium chloride, hinokitiol, triclosan, dipotassium glycyrrhizinate, and salicylic acid.
  15.  前記成分Dが、HLB9.0~13.0のポリエチレングリコール脂肪酸エステル型非イオン性界面活性剤を含む、請求項1~14のいずれか一項に記載のフォーム状皮膚洗浄料。 The foamy skin cleanser according to any one of claims 1 to 14, wherein the component D comprises polyethylene glycol fatty acid ester type nonionic surfactant of HLB 9.0 to 13.0.
  16.  前記原液が、さらに、前記成分D以外のHLB9.0~13.0のポリエチレングリコール型非イオン性界面活性剤を含有する、請求項1~15のいずれか一項に記載のフォーム状皮膚洗浄料。 The foamy skin cleanser according to any one of claims 1 to 15, wherein the stock solution further comprises a polyethylene glycol type nonionic surfactant of HLB 9.0 to 13.0 other than the component D. .
  17.  前記成分D以外のHLB9.0~13.0のポリエチレングリコール型非イオン性界面活性剤が、ポリオキシエチレン硬化ヒマシ油及びポリオキシエチレンヒマシ油から選ばれる成分を含むことを特徴とする、請求項16に記載のフォーム状皮膚洗浄料。 The polyethylene glycol non-ionic surfactant of HLB 9.0 to 13.0 other than the component D is characterized in that it contains a component selected from polyoxyethylene hydrogenated castor oil and polyoxyethylene castor oil. The foam skin cleanser as described in 16.
PCT/JP2018/035298 2017-09-25 2018-09-25 Foamy skin cleanser WO2019059392A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201880030689.9A CN110612094A (en) 2017-09-25 2018-09-25 Foam-like skin cleaning material
KR1020197033224A KR20190133782A (en) 2017-09-25 2018-09-25 Foam Skin Cleanser

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2017-183580 2017-09-25
JP2017183578A JP7121476B2 (en) 2017-09-25 2017-09-25 foam skin cleanser
JP2017-183579 2017-09-25
JP2017183579 2017-09-25
JP2017-183578 2017-09-25
JP2017183580 2017-09-25

Publications (1)

Publication Number Publication Date
WO2019059392A1 true WO2019059392A1 (en) 2019-03-28

Family

ID=65810904

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/035298 WO2019059392A1 (en) 2017-09-25 2018-09-25 Foamy skin cleanser

Country Status (3)

Country Link
KR (1) KR20190133782A (en)
CN (1) CN110612094A (en)
WO (1) WO2019059392A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210061278A (en) * 2019-11-19 2021-05-27 가부시키가이샤 만다무 Skin cleanser composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7427486B2 (en) * 2020-03-23 2024-02-05 株式会社マンダム foam skin cleanser
JP7216444B1 (en) 2021-12-01 2023-02-01 アピ株式会社 external composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001181609A (en) * 1999-12-27 2001-07-03 Daizo:Kk Aerosol composition
JP2002138045A (en) * 2000-10-30 2002-05-14 Ichimaru Pharcos Co Ltd Inhibitor for inhibiting differentiation induction of pre- adipocyte
JP2005097143A (en) * 2003-09-24 2005-04-14 Kanebo Cosmetics Inc Cleansing cosmetic
JP2010265241A (en) * 2009-05-18 2010-11-25 Daizo:Kk Aerosol composition
JP2013159608A (en) * 2012-02-08 2013-08-19 Masaaki Ishiwatari Surfactant-free oil-in-water type emulsion cleansing agent composition
JP2014189530A (en) * 2013-03-28 2014-10-06 Nof Corp Skin cleanser composition
JP2017095393A (en) * 2015-11-24 2017-06-01 株式会社マンダム Foamy skin cleanser

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4690863B2 (en) 2005-11-11 2011-06-01 ポーラ化成工業株式会社 Aerosol facial cleansing cosmetic
JP2010222323A (en) * 2009-03-25 2010-10-07 Kumano Yushi Kk Makeup remover cosmetic composition
JP2012102194A (en) 2010-11-08 2012-05-31 Mikimoto Pharmaceut Co Ltd Aqueous liquid detergent
JP5707225B2 (en) 2011-05-23 2015-04-22 花王株式会社 Aerosol skin cleanser
WO2016114390A1 (en) * 2015-01-16 2016-07-21 株式会社マンダム Cleansing lotion, sheet cosmetic product, and cosmetic method
JP6369923B2 (en) * 2015-03-30 2018-08-08 株式会社マンダム Foam cosmetic

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001181609A (en) * 1999-12-27 2001-07-03 Daizo:Kk Aerosol composition
JP2002138045A (en) * 2000-10-30 2002-05-14 Ichimaru Pharcos Co Ltd Inhibitor for inhibiting differentiation induction of pre- adipocyte
JP2005097143A (en) * 2003-09-24 2005-04-14 Kanebo Cosmetics Inc Cleansing cosmetic
JP2010265241A (en) * 2009-05-18 2010-11-25 Daizo:Kk Aerosol composition
JP2013159608A (en) * 2012-02-08 2013-08-19 Masaaki Ishiwatari Surfactant-free oil-in-water type emulsion cleansing agent composition
JP2014189530A (en) * 2013-03-28 2014-10-06 Nof Corp Skin cleanser composition
JP2017095393A (en) * 2015-11-24 2017-06-01 株式会社マンダム Foamy skin cleanser

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210061278A (en) * 2019-11-19 2021-05-27 가부시키가이샤 만다무 Skin cleanser composition
CN112891253A (en) * 2019-11-19 2021-06-04 株式会社漫丹 Skin cleanser composition
CN112891253B (en) * 2019-11-19 2023-05-02 株式会社漫丹 Skin cleaning agent composition
KR102529753B1 (en) * 2019-11-19 2023-05-08 가부시키가이샤 만다무 Skin cleanser composition

Also Published As

Publication number Publication date
KR20190133782A (en) 2019-12-03
CN110612094A (en) 2019-12-24

Similar Documents

Publication Publication Date Title
JP6862069B2 (en) Foam skin cleanser
JP4868148B2 (en) Liquid detergent product
JP5754644B2 (en) Liquid detergent composition
WO2011004571A1 (en) Detergent
JP6683524B2 (en) Aqueous cleansing cosmetic
WO2019059392A1 (en) Foamy skin cleanser
JP6571361B2 (en) Foam skin cleanser
JP6795297B2 (en) Foam skin cleanser
JP6645814B2 (en) Foam skin cleanser
JP6237172B2 (en) Liquid detergent composition
JP4546069B2 (en) Non-gas type liquid detergent composition in foam discharge container
JP7121618B2 (en) foam skin cleanser
JP7121617B2 (en) foam skin cleanser
JP2017193625A (en) Liquid detergent composition
JP5669522B2 (en) Liquid detergent composition in former container
JP2011132221A (en) Aqueous liquid cleaning composition
JP7463038B2 (en) Liquid skin cleansing composition
JP5966642B2 (en) Skin cleanser
JP7121476B2 (en) foam skin cleanser
JP5562560B2 (en) Foam cleaning agent
JP2008105989A (en) Cleansing cosmetic
JP7427486B2 (en) foam skin cleanser
JP2019172624A (en) Skin detergent
JP7418920B2 (en) Aerosol type hair remover
US10864149B2 (en) Non-aerosol shaving compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18858176

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 20197033224

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18858176

Country of ref document: EP

Kind code of ref document: A1